Publications

Books

1. Jeste DV and Wyatt RJ: Understanding and Treating Tardive Dyskinesia. New York: Guilford Press Inc. 1982 (363 pages).

2. Jeste DV and Wyatt RJ (eds): Neuropsychiatric Movement Disorders. Washington, DC: American Psychiatric Press. 1984 (150 pages).

3. Jeste DV (ed): Neuropsychiatric Dementias: Current Perspectives. Washington, DC: American Psychiatric Press. 1986 (143 pages).

4. Jeste DV and Zisook S (eds.): Psychosis and Depression in the Elderly. Psychiatric Clinics of North America. Philadelphia: WB Saunders Co. Vol. 11, Number 1, March, 1988 (286 pages).

5. Kane JM, Jeste DV, Barnes TRE, Casey DE, Cole JO, Davis JM, Gualtieri CT, Schooler NR, Sprague R and Wettstein RM: Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Association, 1992 (282 pages).

6. Yassa R, Nair NPV, and Jeste DV (eds.): Neuroleptic-Induced Movement Disorders. New York: Cambridge University Press, 1997 (494 pages).

7. Jeste DV and Friedman J (eds.): Psychiatry for Neurologists. Totowa, New Jersey: Humana Press, 2006 (427 pages).

8. Sunderland T, Jeste DV, Baiyewu O, Sirovatka PJ, and Regier DA (eds): Diagnostic Issues in Dementia: Advancing the Research Agenda for DSM-V. Arlington, VA: American Psychiatric Association, 2007 (145 pages).

9. Mueser KT and Jeste DV (eds): Clinical Handbook of Schizophrenia. New York: Guilford Press, 2008 (650 pages).

10. Depp CA and Jeste DV (eds): Successful Cognitive and Emotional Aging. Washington, DC: American Psychiatric Press, Inc., 2009 (419 pages).

11. Jeste DN and Bell CC: Prevention in Mental Health. Psychiatric Clinics of North America. Elsevier Press, Philadelphia, PA, 2011 (in press).


Journal Articles

1. Shah LP and Jeste DV: Hysteria and its management. Indian Journal of Medical Sciences 23:273 282, 1969.

2. Bagadia VN, Jeste DV, Chawla R, Saraf KR and Shah LP: Trifuperidol in schizophrenia: A clinical trial. Indian Journal of Psychiatry 14:31 37, 1972.

3. Doongaji DR, Jeste DV, Saoji NJ, Kane PV and Ravindranath, S: Unilateral versus bilateral ECT in schizophrenia. British Journal of Psychiatry 123:73 80, 1973.

4. Vahia NS, Doongaji DR, Jeste DV, Ravindranath S, Kapoor SM and Ardhapurkar I: Psychophysiological therapy based on the concepts of Patanjali: A new approach to the treatment of neurotic and psychosomatic disorders. American Journal of Psychotherapy 27: 557 565, 1973.

5. Vahia NS, Doongaji DR, Jeste DV, Kapoor SM, Ardhapurkar I and Ravindranath S: Further experience with the therapy based upon concepts of Patanjali in the treatment of psychiatric disorders. Indian Journal of Psychiatry 15:32 37, 1973.

6. Bagadia VN, Jeste DV, Dave KP, Doshi SV and Shah LP: Depression: (a) A study of demography factors in 233 cases. Indian Journal of Psychiatry 15:209 216, 1973. (b) Family and Psychodynamic study of 233 cases. Indian Journal of Psychiatry 15:217 223, 1973. (c) A clinical study of 233 cases. Indian Journal of Psychiatry 15:224 230, 1973.

7. Jeste DV, Vahia NS and Ravindranath S: A comparative study of doxepin and placebo in depression. Indian Journal of Medical Sciences 27:759 764, 1973.

8. Jeste DV, Sule SM, Vahia VN and Kulkarni VM: Psychiatry and psychological disturbances of pregnancy. Indian Practitioner 26:357 362, 1973.

9. Bagadia VN, Jeste DV, Charegaonkar AS, Pradham PV and Shah LP: Psychological study of 180 cases of epilepsy. Indian Journal of Psychiatry 15:391 401, 1973.

10. Jeste DV, Sule SM, Apte JS and Vahia NS: Gilles de la Tourette's disease: Multiple vocal and motor tics. Indian Journal of Pediatrics 40:435 438, 1973.

11. Jeste DV, Doongaji DR and Mistry PP: Reflex (sensory precipitation) epilepsy: Review and case report. Journal of Postgraduate Medicine 19:90 94, 1973.

12. Vahia NS, Doongaji DR and Jeste DV: Twenty five years of psychiatry in a teaching general hospital (in India). Indian Journal of Psychiatry 16:221 228, 1974.

13. Vahia VN and Jeste DV: Recent advances in treatment of psychiatric disorders. The Indian Practitioner 27:47 54, 1974.

14. Doongaji DR, Jeste, DV, Saoji NJ and Lotlikar KD: Multiple choice examination in psychiatry: A comparative study with other systems of examination. Journal of Postgraduate Medicine 21: 135 143, 1975.

15. Doongaji DR, Sheth AS, Ramesh SP, Jeste DV and Ravindranath, P: A double blind study of pimozide versus chlordiazepoxide in anxiety neuroses. Acta Psychiatrica Belgica 76:632 643, 1976.

16. Jeste DV, Olgiati SV and Ghali AY: Masking of tardive dyskinesia with four times a day administration of chlorpromazine. Diseases of Nervous System 38:755 758, 1977.

17. Jeste DV, Potkin SG, Sinha S, Feder SL and Wyatt RJ: Tardive dyskinesia reversible and persistent. Archives of General Psychiatry 36:585 590, 1979.

18. Jeste DV, and Wyatt RJ: In search of treatment for tardive dyskinesia A review of literature. Schizophrenia Bulletin 5:251 293, 1979.

19. Jeste DV, Gillin JC and Wyatt RJ: Serendipity in biological psychiatry A myth? Archives of General Psychiatry 36:1173 1178, 1979.

20. Jeste DV, Perlow M, Wyatt RJ and Stoff DM: Behavioral effects of amfonelic acid in rats Comparison with amphetamine and apomorphine. Communications in Psychopharmacology 3:41 47, 1979.

21. Jeste DV, Stoff DM, Potkin SG and Wyatt RJ: Amphetamine sensitivity and tardive dyskinesia: An animal model. Indian Journal of Psychiatry 21:362 369, 1979.

22. Jeste DV and Wyatt RJ: Tardive dyskinesia: The syndrome. Psychiatry Annals 10:16 25, 1980.

23. Jeste DV and Wyatt RJ: Tardive dyskinesia: A review of treatment possibilities and their effectiveness. Psychiatry Annals 10:26 38, 1980.

24. Jeste DV and Wyatt RJ: Guidelines for the use of neuroleptics in clinical practice. Psychiatry Annals 10:39 52, 1980.

25. Jeste DV, Wagner RL, Weinberger DR, Rieth KG and Wyatt RJ: Evaluation of CT scans in tardive dyskinesia. American Journal of Psychiatry 137:247 248, 1980.

26. Jeste DV and Smith GP: Unilateral mesolimbio cortical dopamine denervation decreases locomotion in the open field and after amphetamine. Pharmacology, Biochemistry and Behavior 12:453 457, 1980.

27. Bridge TP, Jeste DV, Cutler NR, Phelps BH, Potkin SG, Wise CD, Wagner RL and Wyatt RJ: Catecholamine enzyme activity and cognitive function in older psychiatric patients, nursing home residents and elderly in the community. Gerontologist 20:71, 1980.

28. Jeste DV, Neckers LM, Wagner RL, Wise CD, Staub RA, Rogol A, Potkin SG, Bridge TP and Wyatt RJ: Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia. Journal of Clinical Psychiatry 42:75 77, 1981.

29. Jeste DV and Wyatt RJ: Changing epidemiology of tardive dyskinesia An overview. American Journal of Psychiatry 138:297 309, 1981.

30. Bridge TP, Jeste DV, Wise CD Potkin SG, Phelps BH and Wyatt RJ: Platelet monoamine oxidase in aged general population and elderly chronic schizophrenics. Psychopharmacology Bulletin 17:103 104, 1981.

31. Wyatt RJ, Potkin SG, Kleinman JE, Weinberger DR, Luchins, DJ and Jeste DV: The schizophrenic syndrome: Examples of biological tools for subclassification. Journal of Nervous and Mental Disease 169:100 112, 1981.

32. Jeste DV, DeLisi LE, Zalcman S, Wise CD, Phelps BH, Rosenblatt JE, Potkin SG, Bridge TP and Wyatt RJ: A biochemical study of tardive dyskinesia in young male patients. Psychiatry Research 4:327 331, 1981.

33. Jeste DV, Doongaji DR, Panjwani D, Dataa M, Potkin SG, Karoum F, Thatte S, Sheth AS, Apte JS and Wyatt RJ: Cross cultural study of a biochemical abnormality in paranoid schizophrenia. Psychiatry Research 5:341 352, 1981.

34. Wyatt RJ, Karoum F, Stoff DM, Kleinman JE, Gillin JC, Jeste DV and Potkin SG: Monoamine oxidase phenylethylamine, norepinephrine and schizophrenia. Clinical Genetics 19:437 442, 1981.

35. Jeste DV and Wyatt RJ: Dogma disputed: Is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity? Journal of Clinical Psychiatry 42:455 457, 1981.

36. Donnelly EF, Jeste DV and Wyatt RJ: Tardive dyskinesia and perceptual dysfunction. Perceptual and Motor Skills 53:689 690, 1981.

37. Jeste DV, Kleinman JE, Potkin SG, Luchins DJ and Weinberger DR: Ex uno multi: Subtyping the schizophrenia syndrome. (Recipient of the A.E. Bennett Research Award for 1981) Biological Psychiatry 17:199 222, 1982.

38. Cutler NR, Jeste DV, Karoum F and Wyatt RJ: Low dose apomorphine reduces plasma homovanillic acid concentrations in medicated schizophrenic patients. Life Sciences 30:753 756, 1982.

39. Linnoila M, Rosenblatt JE, Jeste DV, Skinner T, Potter WZ and Wyatt RJ: Disparate serum thioridazine concentrations: HPLC vs radioreceptor assay. Acta Pharmacologica et Toxicologica 50:25 29, 1982.

40. Jeste DV and Wyatt RJ: Therapeutic strategies against tardive dyskinesia Two decades of experience. Archives of General Psychiatry 39:803 816, 1982.

41. Doongaji DR, Sheth AS, Desai AB, Apte JS, Thatte S, Vahora SA, Parikh MD and Jeste DV: Use of metoclopramide in the differential diagnosis of drug induced involuntary movements. Journal of Postgraduate Medicine 28:101 106, 1982.

42. Wagner RL, Jeste DV, Phelps BH and Wyatt RJ: Enzyme studies of tardive dyskinesia. I. One year biochemical follow up. Journal of Clinical Psychopharmacology 2:312 314, 1982.

43. DeLisi LE, Jeste DV, Phelps BH and Wyatt RJ: Enzyme studies in tardive dyskinesia. II. Familial aspects. Journal of Clinical Psychopharmacology 2:315 317, 1982.

44. Jeste DV, Linnoila M, Forids CM, Phelps BH, Wagner RL and Wyatt RJ: Enzyme studies in tardive dyskinesia. III. Noradrenergic hyperactivity in a subgroup of TD patients. Journal of Clinical Psychopharmacology 2:318 320, 1982.

45. Jeste DV and Wyatt RJ: Guest Editorial: Neuroleptics and tardive dyskinesia: Quo vadis? Journal of Clinical Psychopharmacology 2:303 304, 1982.

46. Doongaji DR, Jeste DV, Jape NM, Sheth AS, Apte JS, Vahia VN, Desai AB, Vahora A, Thatte S, Vevaina T and Bharadwaj J: Tardive dyskinesia in India: A prevalence study. Journal of Clinical Psychopharmacology 2:341 344, 1982.

47. Jeste DV, Linnoila M, Wagner RL and Wyatt RJ: Serum neuroleptic concentrations and tardive dyskinesia. Psychopharmacology 76:377 380, 1982.

48. Stoff DM, Jeste DV, Moja EA, Stauderman KA and Wyatt RJ: Interaction of monoamine blocking agents with behavioral effects of N,N dimethyltryptamine. Psychopharmacology Bulletin 18:173 175, 1982.

49. Doongaji DR, Jeste DV, Jape NM, Sheth AS, Apte JS, Vahia VN, Desai AB, Rathi LG, Gandhi MH, Parikh RM, Thatte S and Bharadwaj J: Effects of Intravenous metoclopramide in 81 patients with tardive dyskinesia. Journal of Clinical Psychopharmacology 2:376 379, 1982.

50. Jeste DV, Zalcman S, Weinberger DR, Bigelow LB, Kleinman JE, Rogol A, Gillin JC and Wyatt RJ: Apomorphine response and subtyping of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 7:83 88, 1983.

51. Karson CN, Jeste DV, LeWitt PA and Wyatt RJ: A comparison of two iatrogenic dyskinesias. American Journal of Psychiatry 140:1504 1506, 1983.

52. Karson CN, Kleinman JE, Berman KF, Phelps BH, Wise CD, DeLisi LE and Jeste DV: An inverse correlation between spontaneous eye blinks and platelet monoamine oxidase. British Journal of Psychiatry 142:43 46, 1983.

53. Jeste DV, Cutler NR, Kaufmann CA and Karoum F: Low dose apomorphine and bromocriptine in neuroleptic induced movement disorders. Biological Psychiatry 18:1085 1091, 1983.

54. Jeste DV, Stoff DM, Freed WJ, Rawlings R and Wyatt RJ: Use of recombinant inbred strains of mice: An approach to psychopharmacogenetics. Psychopharmacology Bulletin 19:619 620, 1983.

55. Stoff DM, Jeste DV, Gillin JC, Moja EA, Cohen L, Stauderman KA and Wyatt RJ: Behavioral supersensitivity to B phenylethylamine after chronic administration to haloperidol. Biological Psychiatry 19:101 106, 1984.

56. Jeste DV, Doongaji DR and Linnoila M: Elevated cerebrospinal fluid norepinephrine in tardive dyskinesia. British Journal of Psychiatry 144:177 180, 1984.

57. Jeste DV, Barban L, Karson CN, Waldman I, Patterson D, Anderson C and Wyatt RJ: Psychopathology and dyskinesia. Psychopharmacology Bulletin 20:41, 1984.

58. Freed WJ, Crump S and Jeste DV: Genetic effects of PCP induced stimulation in recombinant inbred strains of mice. Pharmacology, Biochemistry, and Behavior 21:159 162, 1984.

59. Cutler NR, Jeste DV, Kaufmann CA, Karoum F, Schran HF and Wyatt RJ: Low dose bromocriptine: A study of acute effects in chronic medicated schizophrenics. Progress in Neuro-Psychopharmacology and Biological Psychiatry 8:277 283, 1984.

60. Jeste DV, Barban L and Parisi J: Reduced Purkinje cell density in Huntington's disease. Experimental Neurology 85:78 86, 1984.

61. Jeste DV, Karson CN, Iager A, Bigelow LB and Wyatt RJ: Association of abnormal involuntary movements and negative symptoms. Psychopharmacology Bulletin 20:380 381, 1984.

62. Bridge TP, Jeste DV, Wise CD, Potkin SG, Phelps BH and Wyatt RJ: Schizophrenic outcome in late life: Symptom state and platelet monoamine oxidase activity. Psychiatry Research 11:91 97, 1984.

63. Jeste DV, Stoff DM, Rawlings R and Wyatt RJ: Pharmacogenetics of phenylethylamine: Determination of heritability and genetic transmission of locomotor effects of recombinant inbred strains of mice. Psychopharmacology 84:537 540, 1984.

64. Jeste DV and Wyatt RJ: Prevention and management of tardive dyskinesia. Journal of Clinical Psychiatry 46:4(Sec. 2):14 18, 1985.

65. Karson CN, Jeste DV and Bigelow LB: Tardive dyskinesia and psychopathology in chronic schizophrenic patients. A cross sectional study. Comprehensive Psychiatry 26:388 391, 1985.

66. Jeste DV, del Carmen R, Lohr J and Wyatt RJ: Did schizophrenia exist before the eighteenth century? Comprehensive Psychiatry 26:493 503, 1985.

67. Jeste DV: An update on tardive dyskinesia: What we know in 1985. Currents in Affective Illness 4(9):5-10, 1985.

68. Kaufmann CA, Jeste DV, Linnoila M, Shelton R, Kafka M and Wyatt RJ: Noradrenergic and neuroradiologic abnormalities in tardive dyskinesia. Biological Psychiatry 21:799 812, 1986.

69. Iager AC, Kirch DG, Jeste DV and Wyatt RJ: Defect symptoms and abnormal involuntary movement in schizophrenia. Biological Psychiatry 21:751 755, 1986.

70. Lohr JB and Jeste DV: Cerebellar pathology in schizophrenia? A neuronometric study. Biological Psychiatry 21:865 875, 1986.

71. Mani RB, Lohr JB and Jeste DV: Hippocampal pyramidal cells and aging in the human: A quantitative study of neuronal loss in sectors CAI CA4. Experimental Neurology, 94:29-40, 1986.

72. David AS, Jeste DV, Folstein MF and Folstein SE: Voluntary movement dysfunction in Huntington's disease and tardive dyskinesia. Acta Neurol. Scand., 75:130-139, 1987.

73. Lohr JB, Lohr MA, Hilliard B, Larson L, Vardiman E, Wade L, Wasli E and Jeste DV: Self perception of tardive dyskinesia and neuroleptic induced parkinsonism: A study of clinical correlates. Psychopharmacology Bulletin, 23:211-214, 1987.

74. Glazer WM, Morgenstern H, Jeste DV, Zahner G, Hafez HM and Benarroche CL: Serum dopamine beta hydroxylase activity and tardive dyskinesia. Psychoneuroendocrinology 12:289-294, 1987.

75. Jeste DV and Zisook S: Preface to Psychosis and Depression in the Elderly. Psychiatric Clinics of North America. 11:xiii-xv, 1988.

76. Jeste DV, Harris MJ, Pearlson GD, Rabins P, Lesser I, Miller B, Coles C and Yassa R: Late-onset schizophrenia: Studying clinical validity. Psychiatric Clinics of North America 11:1-14, 1988.

77. Dupont R, Cullum CM and Jeste DV: Post-stroke depression and psychosis. Psychiatric Clinics of North America 11:133-150, 1988.

78. Wragg RE and Jeste DV: Neuroleptics and alternative treatments: Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions. Psychiatric Clinics of North America. 11:195-214, 1988.

79. Sargenti CJ, Rizos AL and Jeste DV: Psychotropic drug reactions in the patient with late-onset psychosis and mood disorder: Part I. Psychiatric Clinics of North America. 11:235-252, 1988.

80. Rizos AL, Sargenti CJ and Jeste DV: Psychotropic drug reactions in the patient with late-onset depression or psychosis: Part II. Psychiatric Clinics of North America. 11:253-278, 1988.

81. Harris MJ and Jeste DV: Late onset schizophrenia: An overview. Schizophrenia Bulletin 14:39-55, 1988.

82. Jeste DV and Jeste SD: Neuroleptic-induced tardive dyskinesia. Clinical Advances in the Treatment of Psychiatric Disorders 2(3):7 and 10, 1988.

83. Lohr JB and Jeste DV: Locus ceruleus morphology in aging and schizophrenia. Acta Psychiatrica Scandinavia 77:689-697, 1988.

84. Carpenter WT, Schooler NR, Wise SS, Goldman H, Goldstein MJ, Hogarty GE, Jeste DV, Kane JM, Klerman GL, Liberman RP, Paul SM, Robinson DS, Spring B, Stahl SM, and Tamminga CA: A national plan for treatment, services and environmental factors. Schizophrenia Bulletin 14:427-437, 1988.

85. Harris MJ, Cullum CM and Jeste DV: Clinical presentation of late-onset schizophrenia. Journal of Clinical Psychiatry 49:356-360, 1988.

86. Jeste DV, Lohr JB, Clark K and Wyatt RJ: Pharmacological treatment of tardive dyskinesia in the 1980's. Journal of Clinical Psychopharmacology 8(#4, Aug 88 supplement):38S-48S, 1988.

87. Yassa R and Jeste DV: Tardive dyskinesia 1988: Thirty-one years later. Journal of Clinical Psychopharmacology (8)(#4, August 88 supplement):1S, 1988.

88. Shiromani PJ, Armstrong DM, Berkowitz A, Jeste DV and Gillin JD: Distribution of choline acetyltransferase immunoreactive somata in the feline brain stem: Implications for REM sleep generation sleep. Sleep Vol 11, No. 1, pp 1-16, 1988.

89. Lam RW, Jeste SD and Jeste DV: Preventing neuroleptic-induced tardive dyskinesia in adults and children. L'Encephale 14:251-255, 1988.

90. Caligiuri MP, Harris MJ and Jeste DV: Quantitative analyses of voluntary orofacial motor control in schizophrenia and tardive dyskinesia. Biological Psychiatry 24:787-800, 1988.

91. Lohr JB, Cadet JL, Lohr MA, Larson L, Wasli E, Wade L, Hylton R, Vidoni C, Jeste DV and Wyatt RJ: Vitamin E in the treatment of tardive dyskinesia: The possible involvement of free radical mechanisms. Schizophrenia Bulletin 14:291-296, 1988.

92. Jeste DV, Lohr JB and Goodwin FK: Neuroanatomical studies of major affective disorders: A review and suggestions for further research. British Journal of Psychiatry 153:444-459, 1988.

93. Jeste DV, Harris MJ and Rockwell E: Is pseudodementia a pseudo entity? Bulletin of Clinical Neuroscience 53:20-24, 1988.

94. Ko G, Zhang LD, Yan WW, Zhang MD, Buchner D, Xia ZY, Wyatt RJ and Jeste DV: The Shanghai 800: Tardive dyskinesia prevalence in China. American Journal of Psychiatry 146:387-389, 1989.

95. Harris MJ and Jeste DV: Evaluation and management of HIV/AIDS and psychosis. Clinical Advances in the Treatment of Psychiatric Disorders 3:2:8-9, 1989.

96. Wragg RE and Jeste DV: Overview of depression and psychosis in Alzheimer's disease. American Journal of Psychiatry 146:5:577-587, 1989.

97. Jeste DV and Lohr JB: Hippocampal pathologic findings in schizophrenia: A morphometric study. Archives of General Psychiatry 46:1019-1024, 1989.

98. Lawson WB, Jeste DV, Kopp V, Wyatt RJ and Hanin I: RBC and plasma choline in neuroleptic treated schizophrenic patients. Psychiatry Research 29:45-53, 1989.

99. Sewell D and Jeste DV: Neuroleptic malignant syndrome: A review. Japanese Journal of Psychopharmacology 9:319-333, 1989.

100. Caligiuri MP, Jeste DV and Harris MJ: Instrumental assessment of lingual motor instability in tardive dyskinesia. Neuropsychopharmacology 2:309-312, 1989.

101. Jeste DV, Harris MJ, Grant I and Thal L: Psychopathology in dementia. Bulletin of Clinical Neuroscience 54:51-58, 1989.

102. Lohr JB, Kuczenski R, Bracha HS, Moir M and Jeste DV: Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biological Psychiatry 28:535-539, 1990.

103. Jeste DV, Gierz M and Harris MJ: Pseudodementia: Myths and reality. Psychiatry Annals 20:71-79, 1990.

104. Jeste DV and Krull AJ: Editorial: Neuroleptics and tardive dyskinesia: A case of iatrogenesis. Western Journal of Medicine, 153:5:560-561, 1990.

105. Jeste DV, Krull AJ and Kilbourn K: Tardive dyskinesia: Managing a common neuroleptic side effect. Geriatrics 45:12:49-54, 1990.

106. Gariano RF, Young SJ, Jeste DV, Segal DS and Groves PM: Effects of long-term administration of haloperidol on electrophysiological properties of rat mesencephalic neurons. Journal of Pharmacology and Experimental Therapeutics 225 (1):108-113, 1990.

107. Caligiuri MP, Lohr JB, Bracha HS and Jeste DV: Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biological Psychiatry 29: 139-148, 1991.

108. Krull AJ, Press G, Dupont R, Harris MJ and Jeste DV: Brain imaging in late-onset schizophrenia and related psychoses. International Journal of Geriatric Psychiatry, 6:651-658, 1991.

109. Caligiuri MP, Lohr JB and Jeste DV: Instrumental evidence that age increases motor instability in neuroleptic-treated patients. Journal of Gerontology 46:197-200, 1991.

110. Harris MJ, Jeste DV, Gleghorn A and Sewell D: New onset psychosis in HIV-infected patients. Journal of Clinical Psychiatry 52:369-376, 1991.

111. Jeste DV and Krull AJ: Behavioral problems associated with dementia: Diagnosis and treatment. Geriatrics 46:28-34, 1991.

112. Jeste DV and Caligiuri MP: Biological research in geriatric psychiatry. Biological Psychiatry 30:855-856, 1991.

113. Jeste DV, Wragg RE, Salmon DP, Harris MJ and Thal LJ: Cognitive deficits of patients with Alzheimer disease with and without delusions. American Journal of Psychiatry 149:184-189, 1992.

114. Harris MJ, Jeste DV, Krull A, Montague J and Heaton RK: Deficit syndrome in older schizophrenic patients. Psychiatry Research. 29:285-292, 1992.

115. Jeste DV, Lohr JB and Manley M: Study of neuropathologic changes in the striatum following four, eight and twelve months of treatment with fluphenazine in rats. Psychopharmacology. 106:154-160, 1992.

116. Lesser IM, Jeste DV, Boone KB, Harris MJ, Miller B, Heaton RK and Hill-Gutierrez E: Late-onset psychotic disorder, not otherwise specified (NOS): Clinical, neuropsychological and neuroimaging findings. Biological Psychiatry. 31:419-423, 1992.

117. Harris MJ, Panton D, Caligiuri MP, Krull AJ, Tran-Johnson TK and Jeste DV: High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics. Psychopharmacology Bulletin, 28: 87-92, 1992.

118. Lauriello J and Jeste DV: Neuroleptic treatment of schizophrenia. Comprehensive Therapy, 18: 30-35, 1992.

119. Sewell DD and Jeste DV: Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases. Journal of Neuropsychiatry and Clinical Neurosciences, 4: 265-269, 1992.

120. Yassa R and Jeste DV: Gender differences in tardive dyskinesia: A critical review of the literature. Schizophrenia Bulletin, 18(4): 701-715, 1992.

121. Sewell DD and Jeste DV: Metoclopramide-associated tardive dyskinesia: An analysis of 67 cases. Archives of Family Medicine, 1: 271-278, 1992.

122. Sewell DD, Yoshinobu BH, Caligiuri MP and Jeste DV: Metoclopramide-associated tardive dyskinesia in hemodialysis patients with diabetes mellitus: Two case reports. General Hospital Psychiatry, 14: 416-419, 1992.

123. Jeste DV, Fitten LJ, Clemons B, O'Neal S and Harris MJ: A survey of geriatric psychiatrists in the U.S. regarding research. International Journal of Geriatric Psychiatry, 8: 13-18, 1993.

124. Lacro JP, Harris MJ and Jeste DV: Late-life psychosis. International Journal of Geriatric Psychiatry, 8: 49-57, 1993.

125. Gierz M and Jeste DV: Physical comorbidity in elderly veterans affairs patients with schizophrenia and depression. American Journal of Geriatric Psychiatry, 1: 165-170, 1993.

126. Jeste DV: Late-onset schizophrenia (Editorial): International Journal of Geriatric Psychiatry, 8: 283-285, 1993.

127. Jeste DV and Caligiuri MP: Tardive dyskinesia. Schizophrenia Bulletin 19:303-315, 1993.

128. Caligiuri MP, Lohr JB and Jeste DV: Parkinsonism in neuroleptic-naive schizophrenic patients. American Journal of Psychiatry 150:1343-1348, 1993.

129. Jeste DV: Late-life schizophrenia: Editor's Introduction. Schizophrenia Bulletin 19(4):687-689, 1993.

130. Prager S and Jeste DV: Sensory impairment in late-life schizophrenia. Schizophrenia Bulletin 19(4):755-772, 1993.

131. Jeste DV, Lacro JP, Gilbert PL, Kline J and Kline N: Treatment of late-life schizophrenia with neuroleptics. Schizophrenia Bulletin 19(4):817-830, 1993.

132. Copeland JRM and Jeste, DV: Geriatric psychiatry: Editorial overview. Current Opinion in Psychiatry 6:529-530, 1993.

133. Rockwell E, Krull AJ, Dimsdale J and Jeste DV: Late-onset psychosis with somatic delusions. Psychosomatics 35:66-72, 1994.

134. Lacro JP, Sewell DD, Warren K, Woody S, Harris MJ and Jeste DV: Improving documentation of consent for neuroleptic therapy. Hospital and Community Psychiatry 45(2):176-178, 1994.

135. Sewell DD, Jeste DV, Atkinson JH, Heaton RK, Hesselink JR, Wiley C, Thal L, Chandler JL, Grant I and the HNRC Group: HIV-associated psychosis: A study of 20 cases. American Journal of Psychiatry 151(2):237-242, 1994.

136. Rockwell E, Jackson E, Vilke G and Jeste DV: A study of delusions in a large cohort of Alzheimer's disease patients. American Journal of Geriatric Psychiatry 2(2):157-164, 1994.

137. Paulsen JS, Heaton R and Jeste DV: Neuropsychological impairment in tardive dyskinesia. Neuropsychology 8(2):227-241, 1994.

138. Heaton R, Paulsen J, McAdams LA, Kuck J, Zisook S, Braff D, Harris MJ and Jeste DV: Neuropsychological deficits in schizophrenics: Relationship to age, chronicity and dementia. Archives of General Psychiatry 51:469-476, 1994.

139. Sewell DD, Jeste DV, McAdams L, Bailey A, Harris MJ, Atkinson JH, Chandler JL, McCutchan JA, Grant I and the HNRC Group: Neuroleptic Treatment of HIV-Associated Psychosis. Neuropsychopharmacology 10:223-229, 1994.

140. Jeste DV: Geriatric psychiatry in the next millennium (Editorial comment). Current Opinion in Psychiatry 7:4:335-336, 1994.

141. Lacro JP and Jeste DV: Physical comorbidity and polypharmacy in older psychiatric patients. Biological Psychiatry, 36:146-152, 1994.

142. Lacro JP, Gilbert PL, Paulsen JS, Fell R, Bailey A, Juels C, Caligiuri M, McAdams LA, Harris MJ and Jeste DV: Early course of new-onset tardive dyskinesia in older patients. Psychopharmacology Bulletin 30(2):187-191, 1994.

143. Jeste DV; Gottlieb GL, Katz, IR: Fundamentals-oriented clinical research: The need for reconsideration. Guest Editorial. American Journal of Geriatric Psychiatry 2(4):282-284, 1994.

144. Sewell DD, Kodsi AB, Caligiuri MP and Jeste DV: Metoclopramide and Tardive Dyskinesia. Biological Psychiatry 36:630-632, 1994.

145. Cullum CM, Heaton RK, Harris MJ and Jeste DV: Neurobehavioral and neurodiagnostic aspects of late-onset psychosis. Archives of Clinical Neuropsychology 9(5):371-382, 1994.

146. Dupont RM, Lehr P, Lamoureaux G, Halpern S, Harris MJ and Jeste DV: Preliminary Report: Cerebral blood flow abnormalities in older schizophrenic patients. Psychiatry Research: Neuroimaging, 55:121-130, 1994.

147. Granholm E and Jeste DV: Cognitive impairment in schizophrenia. Psychiatric Annals 24:484-490, 1994.

148. Gierz M, Sewell DD, Kramer R, Gillin JC and Jeste DV: Psychotic versus nonpsychotic depression in older patients. American Journal of Geriatric Psychiatry, 3(1): 75-80, 1995.

149. Paulsen JS, Heaton RK, Sadek JR, Perry W, Delis DC, Braff D, Kuck J, Zisook S and Jeste DV: The nature of learning and memory impairments in schizophrenia. Journal of International Neuropsychology Society 1:88-99, 1995.

150. Corey-Bloom J, Jernigan T, Archibald S, Harris MJ and Jeste DV: Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. American Journal of Psychiatry 152:447-449, 1995.

151. Gilbert PL, Harris MJ, McAdams LA and Jeste DV: Neuroleptic withdrawal in schizophrenic patients: A review of the literature. Archives of General Psychiatry, 52:173-188, 1995.

152. Jeste DV, Gilbert P, McAdams LA and Harris MJ: Considering neuroleptic maintenance and taper on a continuum: Need for individual, rather than dogmatic, approach. Archives of General Psychiatry, 52:209-212, 1995.

153. Jeste DV, Harris MJ, Krull A, Kuck J, McAdams LA and Heaton, R: Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. American Journal of Psychiatry 152(5):722-730, 1995.

154. Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, Bailey A, Fell RL and McAdams LA: Risk of tardive dyskinesia in older patients: A prospective longitudinal study of 266 outpatients. Archives of General Psychiatry, 52:756-765, 1995.

155. Hayashi T, Yamawaki S, Nishikawa T, Jeste DV: Usage and side effects of neuroleptics in elderly Japanese patients. American Journal of Geriatric Psychiatry, 3:308-316, 1995.

156. Christensen K, Haroun A, Schneiderman LJ and Jeste DV: Decision-making capacity for informed consent in the older population. Bulletin of the American Academy of Psychiatry and the Law, 23:353-365, 1995.

157. Zisook S, Byrd D, Kuck J and Jeste DV: Command hallucinations in outpatients with schizophrenia. Journal of Clinical Psychiatry, 56(10):462-465, 1995.

158. Koran LM, Holman S, Hertzman M, Meyers BS, Halaris AE, Tollefson GD, Downs JM, Folks DG, Jeste DV, Lazarus LW and Satlin A: Predicting response to fluoxetine in geriatric patients with major depression. Journal of Clinical Psychopharmacology, 15(6):421-427, 1995.

159. Naimark D, Jackson E, Rockwell E and Jeste DV: Psychotic symptoms in Parkinson's disease patients with dementia. Journal of the American Geriatrics Society 44(3):296-299, 1996.

160. Jeste DV, Heaton SC, Paulsen JS, Ercoli L, Harris MJ and Heaton RK: Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia. American Journal of Psychiatry 153(4):490-496, 1996.

161. Paulsen JS, Caligiuri MP, Palmer B, McAdams LA and Jeste DV: Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: A prospective longitudinal study. Psychopharmacology 123:307-314, 1996.

162. McAdams LA, Harris MJ, Bailey A, Fell R and Jeste DV: Validating specific psychopathology scales in older outpatients with schizophrenia. The Journal of Nervous and Mental Disease 184(4):246-251, 1996.

163. Jeste DV, Eastham JH, Lacro JP, Gierz M, Field MG, Harris, MJ: Management of late-life psychosis. Journal of Clinical Psychiatry 57(Supp. 3):39-45, 1996.

164. Cuffel BJ, Jeste DV, Patterson TL, Halpain M, Pratt C: Treatment costs and use of community mental health services for schizophrenia by age-cohorts. American Journal of Psychiatry 153(7): 870-876, 1996.

165. Lacro JP, Eastham JH, Jeste DV and Lohr JB: Newer antipsychotics and antidepressants for elderly people. Current Opinion in Psychiatry 9(4):290-293, 1996.

166. Jeste DV: Growing disparity between need and reality: Research in geriatric psychiatry (Editorial). Current Opinion in Psychiatry 9(4):279-280, 1996.

167. Granholm E, Asarnow RF, Verney SP, Nelson P and Jeste DV: Span of apprehension deficits in older outpatients with schizophrenia. Schizophrenia Research 20:51-56, 1996.

168. Lacro JP, Kuczenski R, Roznoski M, Warren KA, Harris MJ and Jeste DV: Serum haloperidol levels in older psychotic patients. American Journal of Geriatric Psychiatry 4:229-236, 1996.

169. Jeste DV, Lindamer LA, Evans J and Lacro JP: Relationship of ethnicity and gender to schizophrenia and pharmacology of neuroleptics. Psychopharmacology Bulletin 32(2):243-251, 1996.

170. Jeste DV, Gladsjo JA, Lindamer LA and Lacro JP: Medical comorbidity in schizophrenia. Schizophrenia Bulletin 22(3):413-430, 1996.

171. Rapaport MH, Bazzetta J, McAdams LA, Patterson T and Jeste DV: Validation of the scale of functioning in older outpatients with schizophrenia. American Journal of Geriatric Psychiatry 4(3):218-228, 1996.

172. Perry W, Potterat E, Auslander L, Kaplan E and Jeste DV: A neuropsychological approach to the Rorschach in patients with dementia of the Alzheimer type. Assessment (special issue on Neuropsychology of Personality). Assessment 3(3):351-363, 1996.

173. Evans JD, Paulsen JS, Harris MJ, Heaton RK and Jeste DV: A Clinical and neuropsychological comparison of delusional disorder and schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences. 8(3):281-286, 1996.

174. Eastham JH, Lacro JP and Jeste DV: Ethnicity and movement disorders. The Mount Sinai Journal of Medicine 63(5&6):314-319, 1996.

175. Patterson TL, Kaplan RM, Grant I, Semple SJ, Moscona S, Koch WL, Harris MJ and Jeste DV: Quality of well-being in late-life psychosis. Psychiatry Research 63:169-181, 1996.

176. Patterson TL, Semple SJ, Shaw WS, Grant I and Jeste DV: Researching the caregiver: Family members who care for older psychotic patients. Psychiatric Annals 26(12) 772-784, 1996.

177. Palmer BW and Jeste DV: Neurodevelopmental theories of schizophrenia: Application to late-onset schizophrenia. Indian Journal of Psychiatry 38(1):13-22, 1996.

178. Paulsen JS, Romero, R., Chan A, Davis AV, Heaton RK and Jeste DV: Impairment of the semantic network in schizophrenia. Psychiatry Research 63:109-121, 1996.

179. Eastham JH and Jeste DV: Differentiating behavioral disturbances of dementia from drug side effects. International Psychogeriatrics 8(3):429-434, 1996.

180. Jeste DV, Rockwell E, Harris MJ, Eastham J and Lacro J: New research on psychotic symptoms in schizophrenia. Clinical Geriatrics Supplement A:10-15, January 1997.

181. Jeste DV and Kelsoe JR: Schizophrenia, tardive dyskinesia and a D3 receptor gene variant: A new twist on dyskenesias? Molecular Psychiatry 2:86-88, 1997.

182. Patterson TL, Shaw W, Semple SJ, Moscona S, Harris MJ, Kaplan RM, Grant I and Jeste DV: Health-related quality of life in older patients with schizophrenia and other psychoses: Relationships among psychosocial and psychiatric factors. International Journal of Geriatric Psychiatry 12(4):452-461, 1997.

183. Lopez W and Jeste DV: Movement disorders and substance abuse. Psychiatric Services 48(5):634-636, 1997.

184. Klapow JC, Evans J, Patterson TL, Heaton RK, Koch WL and Jeste DV: Direct assessment of functional status in older patients with schizophrenia. American Journal of Psychiatry 154:1022-1024, 1997.

185. Olichney JM, Iragui VJ, Kutas M, Nowacki R and Jeste DV: N400 Abnormalities in late life schizophrenia and related psychoses. Biological Psychiatry 42:13-23, 1997.

186. Semple SJ, Patterson TL, Shaw WS, Grant I, Moscona S, Koch W, Jeste DV and the CRC on Late Life Psychosis Research Group: The social networks of older schizophrenia patients. International Psychogeriatrics, 9(1):81-94, 1997.

187. Halpain M, Jeste DV, Katz IR and Lebowitz BD: The first summer research institute in geriatric psychiatry. American Journal of Geriatric Psychiatry, 5(3):238-246, 1997.

188. Jeste DV, Klausner M, Brecher M, Clyde C, Jones R and the ARCS Study Group: A clinical evaluation of risperidone in the treatment of schizophrenia: A 10-week, open-label, multicenter trial. Psychopharmacology 131(3):239-247, 1997.

189. Lindamer LA, Lohr JB, Harris MJ and Jeste DV: Gender, estrogen, and schizophrenia. Psychopharmacology Bulletin 33(2):221-228, 1997.

190. Palmer BW, Heaton RK, Paulsen JS, Kuck J, Braff D, Harris MJ, Zisook S and Jeste DV: Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 11(3):437-446, 1997.

191. Lacro JP and Jeste DV: Geriatric psychosis. Psychiatric Quarterly 68(3):247-260, 1997.

192. Granholm E, Morris SK, Sarkin AJ, Asarnow RF and Jeste DV: Pupillary responses index overload of working memory resources in schizophrenia. Journal of Abnormal Psychology 106(3):458-467, 1997.

193. Caligiuri MP, Lacro JP, Rockwell E, McAdams LA and Jeste DV: Incidence and risk factors for severe tardive dyskinesia in older patients. British Journal of Psychiatry 171:148-153, 1997.

194. Jeste DV: Psychiatry of old age is coming of age (Guest editorial). American Journal of Psychiatry 154(10):1356-1358, 1997.

195. Symonds LL, Olichney JM, Jernigan TL, Corey-Bloom J, Healy JF and Jeste DV: Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses. The Journal of Neuropsychiatry and Clinical Neurosciences 9(2):251-258, 1997.

196. Eastham JH and Jeste DV: Treatment of schizophrenia and delusional disorder in the elderly. European Archives of Psychiatry and Clinical Neuroscience, 247(4):209-218, 1997.

197. Jeste DV, Symonds LL, Harris MJ, Paulsen JS, Palmer BW and Heaton RK: Non-dementia non-praecox dementia praecox?: Late-onset schizophrenia. American Journal of Geriatric Psychiatry 5(4):302-317, 1997.

198. Jeste DV: Schizophrenia, antipsychotics and aging (Guest Editorial). Schizophrenia Research 27: 103-104, 1997.

199. Morris SK, Granholm E, Sarkin AJ and Jeste DV: Effects of schizophrenia and aging on pupillographic measures of working memory. Schizophrenia Research 27:119-128, 1997.

200. Kindermann SS, Karimi A, Symonds L, Brown GG and Jeste DV: Review of functional magnetic resonance imaging (fMRI) in schizophrenia. Schizophrenia Research 27:143-156, 1997.

201. Turner EE, Fedtsova N and Jeste DV: The cellular and molecular neuropathology of schizophrenia: New directions from developmental neurobiology. Schizophrenia Research 27:169-180, 1997.

202. Patterson TL, Semple SJ, Shaw WS, Halpain M, Moscona S, Grant I and Jeste DV: Self-reported social functioning among older patients with schizophrenia. Schizophrenia Research 27:199-210, 1997.

203. McAdams LA, Harris MJ, Heaton SC, Bailey A, Fell R and Jeste DV: Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients. Schizophrenia Research 27:219-226, 1997.

204. Jeste DV and Harris MJ: Depression and dementia. Medical Advances - Health in Mind and Body 2(1):5, 1997.

205. Palmer BW, Jeste DV and Sheikh JI: Anxiety disorders in the elderly: DSM-IV and other barriers to diagnosis and treatment. Journal of Affective Disorders, 46:183-190, 1997.

206. Ellis RJ, Jan K, Kawas C, Koller WC, Lyons KE, Jeste DV, Hansen LA and Thal LJ: Diagnostic validity of the dementia questionnaire for Alzheimer’s disease. Archives of Neurology 55:360-365, 1998.

207. Eastham JH, Jeste DV and Young RC: Assessment and treatment of bipolar disorder in the elderly. Drugs and Aging 12(3):205-224,1998.

208. Sciolla A and Jeste DV: Use of antipsychotics in the elderly. International Journal of Psychiatry in Clinical Practice 2: S27-S34, 1998.

209. Caligiuri MP, Rockwell E and Jeste DV: Extrapyramidal side effects in patients with Alzheimer’s disease treated with low-dose neuroleptic medication. American Journal of Geriatric Psychiatry 6 (1): 75-82, 1998.

210. Jeste DV and Davidson M: The pharmacotherapy of psychotic symptoms in the elderly. Clinician 16(1): 22-32, 1998.

211. Jeste DV and Palmer BW: Secondary psychosis: An overview. Seminars in Clinical Neuropsychiatry 3(1): 2-3, 1998.

212. Peyser CE, Naimark D, Zuniga R and Jeste DV: Psychoses in Parkinson’s disease. Seminars in Clinical Neuropsychiatry 3(1): 41-50, 1998.

213. Jeste DV, Lohr JB, Eastham JH, Rockwell E and Caligiuri MP: Adverse effects of long-term use of neuroleptics: Human and animal studies. Journal of Psychiatry Research 32:201-214, 1998.

214. Olichney JM, Iragui VJ, Kutas M, Nowacki R, Morris S and Jeste DV: Relationship between auditory P300 amplitude and age of onset of schizophrenia in older patients. Psychiatry Research 79:241-254, 1998.

215. Jeste DV, McAdams LA, Palmer BW, Braff D, Jernigan TL, Paulsen JS, Stout J, Symonds LL, Bailey A and Heaton RK: Relationship of neuropsychological and MRI measures to age of onset of schizophrenia. Acta Psychiatrica Scandinavica 98: 156-164, 1998.

216. Halpain MC and Jeste DV: Schizophrenia in the elderly. The Journal for the California Alliance for the Mentally Ill: 71-73, 1998.

217. Patterson TL, Klapow JC, Eastham JH, Heaton RK, Evans JD, Koch WL and Jeste DV: Correlates of functional status in older patients with schizophrenia. Psychiatry Research 80:41-52, 1998.

218. Jeste DV: Late paraphrenia is not late-onset schizophrenia but a different illness: Column Con. Journal of Psychotic Disorders 2(4): 3,15, 1998.

219. Jeste DV: Pro/Con: Discussion: Column Con: Rebuttal to the article by Dr. Howard. Journal of Psychotic Disorders 2(4): 16, 1998.

220. Jeste DV, Rockwell E, Harris MJ, Lohr JB and Lacro J: Conventional versus newer antipsychotics in elderly patients. American Journal of Geriatric Psychiatry 7 (1):70-76, 1999.

221. Jeste DV, Lacro JP, Palmer B, Rockwell E, Harris MJ and Caligiuri MP: Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. American Journal of Psychiatry 156: 309-311, 1999.

222. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M for the Risperidone Study Group: Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. Journal of Clinical Psychiatry 60: 107-115, 1999.

223. Lindamer LA, Lohr JB, Harris MJ, McAdams LA and Jeste DV: Gender-related clinical differences in older patients with schizophrenia. Journal of Clinical Psychiatry 60: 61-67, 1999.

224. Palmer BW, Heaton RK and Jeste DV: Extrapyramidal symptoms and neuropsychological deficits in schizophrenia. Biological Psychiatry 45: 791-794, 1999.

225. Gladsjo JA, Heaton RK, Palmer BW, Taylor MJ and Jeste DV: Use of oral reading to estimate premorbid intellectual and neuropsychological functioning. Journal of the International Neuropsychological Society 5: 247-254, 1999.

226. McClure FS, Gladsjo JA and Jeste DV: Late-onset psychosis: Clinical, research, and ethical considerations. American Journal of Psychiatry 156:6; 935-940, 1999.

227. Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ and Caligiuri MP: Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. Journal of the American Geriatrics Society 47: 716-719, 1999.

228. Ancoli-Israel S, Martin J, Jones DW, Caligiuri M, Patterson T, Harris MJ and Jeste DV: Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia. Biological Psychiatry 45: 1426-1432, 1999.

229. Patterson TL, Kaplan RM and Jeste DV: Measuring the effect of treatment on quality of life in patients with schizophrenia: Focus on utility based measures. CNS Drugs. 12(1), 49 64, 1999.

230. Jeste DV, Alexopoulos GS, Bartels SJ, Cummings JL, Gallo JJ, Gottlieb GL, Halpain MC, Palmer BW, Patterson TL, Reynolds CF and Lebowitz BD: Consensus statement on the upcoming crisis in geriatric mental health: Research agenda for the next two decades. Archives of General Psychiatry, 56:848-853, 1999.

231. Jeste DV and Munoz RA: Introduction: Preparing for the future. Psychiatric Services 56:1157, 1999.

232. Cummings JL and Jeste DV: Alzheimer’s disease and its management in the year 2010. Psychiatric Services 50:1173-1177, 1999.

233. Palmer BW, Heaton SC and Jeste DV: Older patients with schizophrenia: Challenges in the coming decades. Psychiatric Services 50:1178-1183, 1999.

234. Patterson TL and Jeste DV: The potential impact of the baby-boom generation on substance abuse among elderly persons. Psychiatric Services 50:1184-1187, 1999.

235. Halpain MC, Harris MJ, McClure FS and Jeste DV: Training in geriatric mental health: Needs and strategies. Psychiatric Services 50:1205-1208, 1999.

236. Evans JD, Negron AE, Palmer BW, Paulsen JS, Heaton RK and Jeste DV: Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients. Journal of Geriatric Psychiatry and Neurology, 12: 11-15, 1999.

237. Magulac M, Landsverk J, Golshan S and Jeste DV: Abnormal involuntary movements in neuroleptic-naive children and adolescents. Canadian Journal of Psychiatry. 44: 368-373, 1999.

238. Caligiuri MP, Lacro JP and Jeste DV: Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics. Journal of Clinical Psychopharmacology, 19:322 328, 1999.

239. Zisook S, McAdams LA, Kuck J, Harris MJ, Bailey A, Patterson TL, Judd LL and Jeste DV: Depressive symptoms in schizophrenia. American Journal of Psychiatry, 156(11): 1736-1743, 1999.

240. Jeste DV, Palmer BW and Harris MJ: Neuroleptic discontinuation in clinical and research settings: Scientific issues and ethical dilemmas. Biological Psychiatry, 46: 1050-1059, 1999.

241. Jeste DV: Introduction: Newer drugs for older patients. Journal of Clinical Psychiatry, 60(supp 3): 3-4, 1999.

242. Lindamer LA and Jeste DV: Estrogen and Psychosis: Is there an association? International Psychiatry Today: 8(2);5 7, 1999.

243. Grundman M, Ellis R, Klauber M, Jeste D, Grant I and Thal LJ: Importance of both clinical and marital status on survival in Alzheimer’s disease. Research and Practice in Alzheimer’s Disease 2:304-316, 1999.

244. Evans JD, Heaton RK, Paulsen JS, McAdams LA, Heaton SC and Jeste DV: Schizoaffective disorder: A form of schizophrenia or affective disorder? Journal of Clinical Psychiatry, 60: 874-882,1999.

245. Semple SJ, Patterson TL, Shaw WS, Grant I, Moscona S and Jeste DV: Self-perceived interpersonal competence in older schizophrenia patients: The role of patient characteristics and psychosocial factors. Acta Psychiatrica Scandinavica 100: 126-135, 1999.

246. Granholm E, Morris S, Asarnow RF, Chock D and Jeste DV: Accelerated age-related decline in processing resources in schizophrenia: Evidence from pupillary responses recorded during the span of apprehension task. Journal of the International Neuropsychological Society, 6: 30-43, 2000.

247. Jeste DV and Finkel SI: Psychosis of Alzheimer’s disease and related dementias: Diagnostic criteria for a distinct syndrome. American Journal of Geriatric Psychiatry 8: 29-34, 2000.

248. Howard R, Rabins P, Seeman MV, Jeste DV and the International Late-Onset Schizophrenia Group: Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: An international consensus. American Journal of Psychiatry, 157:172-178, 2000.

249. Jeste DV, Harless KA and Palmer BW: Chronic late-onset schizophrenia-like psychosis that remitted: Revisiting Newton's psychosis? American Journal of Psychiatry, 157(3): 444-449, 2000.

250. Jeste DV: Tardive dyskinesia in older patients. Journal of Clinical Psychiatry, 61 (suppl 4): 27-32, 2000.

251. Shaw WS, Patterson TL, Semple SJ, Halpain MC, Koch WL, Harris MJ, Grant I and Jeste DV: Use of community support services by middle-aged and older patients with psychotic disorders. Psychiatric Services, 51 (4):506-512, 2000.

252. Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I and Jeste DV: Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology, 54: 1965-1971, 2000.

253. Jeste DV, Okamoto A, Napolitano J, Kane JM and Martinez RA: Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone. American Journal of Psychiatry 157 (7):1150-1155, 2000.

254. Eyler Zorrilla LT, Heaton RK, McAdams LA, Zisook S, Harris JM and Jeste DV: Cross sectional study of older outpatients with schizophrenia and healthy comparison subjects: No differences in age related cognitive decline. American Journal of Psychiatry 157 (8): 1324-1326, 2000.

255. Jeste DV and Lacro JP: Characteristics of an ideal drug for behavioral and psychological symptoms of dementia. International Psychogeriatrics 12 (1): 213-215, 2000.

256. Jeste DV and Glick ID: Editors’ Introduction: Intervention research in psychosis: Past, present, and future. Schizophrenia Bulletin, 26(3): 527-531, 2000.

257. Rockwell E, Choure J, Galasko D, Olichney J and Jeste DV: Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer's Disease: Comparison of matched groups with autopsy-confirmed diagnoses. International Journal of Geriatric Psychiatry 15: 819-823, 2000.

258. Samuel W, Caligiuri MP, Galasko D, Lacro JP, Marini M, McClure FS, Warren K and Jeste DV: Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study. International Journal of Geriatric Psychiatry 15: 794-802, 2000.

259. Ashley RV, Rockwell E, Gladsjo JA and Jeste DV: The reappearance of depression in an elderly man: What is lurking behind? American Journal of Psychiatry 157(12): 1943-1947, 2000.

260. Paulsen JS, Ready RE, Stout JC, Salmon DP, Thal LJ, Grant I and Jeste DV: Neurobehaviors and psychotic symptoms in Alzheimer's disease. Journal of International Neuropsychological Society 6: 815-820, 2000.

261. Caligiuri MP, Jeste DV and Lacro JP: Antipsychotic-induced movement disorders in the elderly: Epidemiology and treatment recommendations. Drugs and Aging 17(5): 363-384, 2000.

262. Jeste DV: Geriatric psychiatry may be the mainstream psychiatry of the future. American Journal of Psychiatry 157(12): 1912-1914, 2000.

263. McQuaid JR, Granholm E, Patterson TL, McClure FS, Roepke S, Pedrelli P and Jeste DV: Development of an integrated cognitive behavioral, social skills training intervention for older patients with schizophrenia. The Journal of Psychotherapy Practice and Research. 9: 149-156, 2000.

264. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD and Jeste DV: Stability and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry 58:24-32, 2001.

265. Martin J, Jeste DV, Caligiuri MP, Patterson T, Heaton R and Ancoli-Israel S: Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia. Schizophrenia Research 47:77-86, 2001.

266. Palmer BW, McClure FS and Jeste DV: Schizophrenia in late-life: Findings challenge traditional concepts. Harvard Review of Psychiatry 9:51-58, 2001.

267. Halpain MC, Jeste DV, Katz IR, Reynolds CF, Small GW, Borson S and Lebowitz BD: Summer Research Institute: Enhancing research career development in geriatric psychiatry. Academic Psychiatry 25:48-56, 2001.

268. Lindamer LA, Buse DC, Lohr JB and Jeste DV: HRT in Postmenopausal women with schizophrenia: Positive effect on negative symptoms? Biological Psychiatry 49:47-51, 2001.

269. Dunn LB and Jeste DV: Enhancing informed consent for research and treatment. Neuropsychopharmacology 24(6): 595-607, 2001.

270. Roepke S, McAdams LA, Lindamer LA, Patterson TL, Jeste DV: Personality profiles among normal aged individuals as measured by the NEO-PI-R. Aging and Mental Health 5(2): 159-164, 2001.

271. Patterson TL, Moscona S, Davidson K and Jeste DV: Social skills performance assessment among older patients with schizophrenia. Schizophrenia Research 48: 351-360, 2001.

272. Auslander LA, Lindamer LL, Delapena J, Harless K, Polichar D, Patterson TL, Zisook S, Jeste DV: A comparison of community-dwelling older schizophrenia patients by residential status. Acta Psychiatrica Scandinavica 103: 380-386, 2001.

273. Sable JA, Jeste DV: Anxiety disorders in older adults. Current Psychiatry Reports 3: 302-307, 2001.

274. Kasckow JW, Twamley E, Mulchahey JJ, Carroll B, Sabai M, Strakowski SM, Patterson T, Jeste DV: Health-related quality of well-being in chronically hospitalized patients with schizophrenia: Comparison with matched outpatients. Psychiatry Research. 103(1): 69-78, 2001.

275. Lindamer LA, Lohr JB, Caligiuri MP, Jeste DV: Relationship of gender and age of onset of schizophrenia to severity of dyskinesia. Journal of Neuropsychiatry and Clinical Neurosciences. 13(3): 399-402, 2001.

276. Ashley RV, Gladsjo A, Olson R, Judd LL, Sewell DD, Rockwell ER, Jeste DV: Changes in psychiatric diagnoses from admission to discharge: Review of the charts of 159 patients consecutively admitted to a geriatric psychiatry inpatient unit. General Hospital Psychiatry. 23: 3-7, 2001.

277. Folsom DP, Jeste DV: Medical comorbidity in people with schizophrenia. Home Health Care Consultant. 8(9): 17-21, 2001.

278. Patterson TL, Goldman S, McKibbin CL, Hughs T and Jeste DV: UCSD Performance -Based Skills Assessment: Development of a new measure of everyday functioning for severely mentally ill adults. Schizophrenia Bulletin. 27(2): 235-245, 2001.

279. Dunn LB, Lindamer LA, Palmer BW, Schneiderman LJ, Jeste DV: Enhancing comprehension of consent for research in older patients with psychosis: A randomized study of a novel consent procedure. American Journal of Psychiatry. 158(11): 1911-1913, 2001.

280. Jin H, Zisook S, Palmer BW, Patterson TL, Heaton RK and Jeste DV: Association of depressive symptoms with worse functioning in schizophrenia: A study of older outpatients. Journal of Clinical Psychiatry 62 (10): 797-803, 2001.

281. Jeste DV: Editorial: Our journal in the new millennium. American Journal of Geriatric Psychiatry 9: 327-329, 2001.

282. Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL, Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins PV, Small GW and Lieberman JA: National Institute of Mental Health - Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer’s Disease Trial Methodology. American Journal of Geriatric Psychiatry 9: 346-360, 2001.

283. Jeste DV and Unutzer J: Guest Editorial: Improving the delivery of care to the seriously mentally ill. Medical Care 39: 907-909, 2001.

284. Kasckow JW, Mohamed S, Thallasinos A, Carroll B, Zisook S and Jeste DV: Citalopram augmentation of antipsychotic treatment in older schizophrenia patients. International Journal of Geriatric Psychiatry 16: 1163-1167, 2001.

285. Granholm E, McQuaid, JR, McClure FS, Pedrelli P and Jeste, DV: A randomized controlled pilot study of cognitive behavioral social skills training for older patients with schizophrenia. Schizophrenia Research 53: 167-169, 2002.

286. Auslander LA, Perry W, Jeste DV: Assessing disturbed thinking and cognition using the ego impairment index in older schizophrenia patients: Paranoid vs. nonparanoid distinction. Schizophrenia Research 53: 199-207, 2002.

287. Dolder CR, Lacro JP, Dunn LB, Jeste DV: Antipsychotic medication adherence: Is there a difference between typical and atypical agents? American Journal of Psychiatry 159: 103-108, 2002.

288. Patterson TL, Lacro J, McKibbin CL, Moscona S, Hughes T and Jeste DV: Medication Management Ability Assessment: Results from a performance-based measure in older outpatients with schizophrenia. Journal of Clinical Psychopharmacology 22: 11-19, 2002.

289. Eyler Zorrilla L, Jeste DV, Brown GG: Functional MRI and Novel Picture Learning among older patients with chronic schizophrenia: Abnormal correlations between recognition memory and medial temporal brain response. American Journal of Geriatric Psychiatry 10: 52-61, 2002.

290. Dunn LB, Lindamer LA, Palmer BW, Golshan S, Schneiderman LJ and Jeste DV: Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. American Journal of Geriatric Psychiatry 10: 142-150, 2002.

291. Saks E, Dunn LB, Marshall BJ, Nayak GV, Golshan S and Jeste DV: The California Scale of Appreciation: A new instrument to measure the appreciation component of capacity to consent to research. American Journal of Geriatric Psychiatry 10: 166-174, 2002.

292. Palmer BW, Nayak GV, Dunn LB, Appelbaum PS and Jeste DV: Treatment-related decision making capacity in middle-aged and older patients with psychosis: A preliminary study using the MacCAT-T and HCAT. American Journal of Geriatric Psychiatry 10: 207-211, 2002.

293. Jin H, Meyer JM and Jeste DV: The phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of 45 published cases. Annals of Clinical Psychiatry 14: 59-64, 2002.

294. Saks ER, Jeste DV, Granholm E, Palmer BW, Schneiderman L: Ethical issues in psychosocial interventions research involving controls. Ethics and Behavior 12: 87-101, 2002.

295. Palmer BW, Heaton RK, Gladsjo JA, Evans JD, Patterson TL, Golshan S, Jeste DV: Heterogeneity in functional status among older outpatients with schizophrenia: Employment history, living situation, and driving. Schizophrenia Research 55: 205-215, 2002.

296. Folsom D, Jeste DV: Schizophrenia in homeless persons: A systematic review of the literature. Acta Psychiatrica Scandinavica 105: 404-413, 2002.

297. Kindermann SS, Dolder CR, Bailey A, Katz IR, Jeste DV: Pharmacological treatment of psychosis and agitation in elderly patients with dementia: Four decades of experience. Drugs and Aging 19: 257-276, 2002.

298. Sable JA and Jeste DV: Antipsychotic treatment for late-life schizophrenia. Current Psychiatry Reports 4: 299-306, 2002.

299. Palmer BW, Folsom D, Bartels S and Jeste DV: Psychotic disorders in late life: Implications for treatment and future directions for clinical services. Generations 26: 29-43, 2002.

300. Auslander LA, Jeste DV: Perceptions of problems and needs for service among older outpatients with schizophrenia and related psychotic disorders. Community Mental Health Journal 38: 391-402, 2002.

301. Mamo DC, Sweet RA, Chengappa KNR, Reddy RR and Jeste DV: The effect of age on pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. International Journal of Geriatric Psychiatry 17: 1012-1017, 2002.

302. Bartels SJ, Dums AR, Oxman TE, Schneider LS, Arean PA, Alexopoulos GS and Jeste DV: Evidence-based practices in geriatric mental health care. Psychiatric Services 53: 1419-1431, 2002.

303. Madhusoodanan S, Bogunovic OJ, Gupta S, Steinmeyer C, Brenner R and Jeste DV: Use of atypical antispychotics in elderly patients with schizophrenia and schizoaffective disorder. Journal of Advances in Schizophrenia and Brain Research 4: 110-122, 2002.

304. Twamley EW, Doshi RR, Nayak G, Palmer BW, Golshan S, Heaton RK, Patterson TL and Jeste DV: Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. American Journal of Psychiatry 159:2013-2020, 2002.

305. Folsom DP, McCahill M, Bartels SJ, Lindamder LA, Ganiats TG and Jeste DV: Medical comorbidity and receipt of medial care by older homeless persons with schizophrenia or depression. Psychiatric Services 53:1456-1460, 2002.

306. Jeste DV, Twamley EW, Eyler Zorrilla LT, Golshan S, Patterson TL and Palmer BW: Aging and outcome in schizophrenia. Acta Psychiatrica Scandinavica 107: 336-343, 2003.

307. Lacro JP, Dunn LB, Dolder CR, Leckband SG and Jeste DV: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry 63: 892-909, 2003.

308. Dolder CR, Lacro JP and Jeste DV: Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Psychosomatic Medicine 65: 156-162, 2003.

309. Patterson TL, McKibbin C, Taylor M, Goldman S, Davila-Fraga W, Bucardo J and Jeste DV: Functional Adaptation Skills Training (FAST): A pilot psychosocial intervention study in middle-aged and older patients with chronic psychotic disorders. American Journal of Geriatric Psychiatry 11: 17-23, 2003.

310. Palmer BW, Bondi MW, Twamley EW, Thal L, Golshan S, Jeste DV: Are late-onset schizophrenia-spectrum disorders neurodegenerative conditions?: Annual rates of change on two dementia measures. Journal of Neuropsychiatry and Clinical Neurosciences 15: 45-52, 2003.

311. Eyler Zorrilla LT, Jeste DV, Paulus M, Brown GG: Functional abnormalities of medial temporal cortex during novel picture learning among patients with chronic schizophrenia. Schizophrenia Research 59: 187-198, 2003.

312. Evans JD, Heaton RK, Paulsen JS, Palmer BW, Patterson T and Jeste DV: The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients. Biological Psychiatry 53: 422-430, 2003.

313. Jeste DV: Editorial: The new and improved journal. American Journal of Geriatric Psychiatry 11:118-119, 2003.

314. Lindamer LA, Buse DC, Auslander A, Unutzer J, Bartels SJ and Jeste DV: A comparison of gynecological variables and services use among older women with and without schizophrenia. Psychiatric Services 54: 902-904, 2003.

315. Dolder CR and Jeste DV: Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biological Psychiatry 53:1142-1145, 2003.

316. Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S and Jeste DV: Cognitive predictors of medication adherence among middle aged and older outpatients with schizophrenia. Schizophrenia Research 63:49-58, 2003.

317. Wetherell JL and Jeste DV: Diagnostic Decision Tree in Dementia. Dialogues in Clinical Neuroscience 5:44-47, 2003.

318. Barrio C, Yamada A-M, Hough R, Hawthorne W, Garcia P and Jeste DV: Ethnic disparities in use of public mental health care management services among patients with schizophrenia. Psychiatric Services 54:1264-1270, 2003.

319. Jin H, Folsom DP, Lindamer L, Bailey A, Hawthorne W, Garcia P and Jeste DV: Patterns of public mental health service use by age in patients with schizophrenia. American Journal of Geriatric Psychiatry 11:525-533, 2003.

320. Dolder CR, Lacro JP, Leckband S and Jeste DV: Interventions to improve antipsychotic medication adherence: Review of recent literature. Journal of Clinical Psychopharmacology 23:389-399, 2003.

321. Jeste DV: A Wednesday in summer. Academic Psychiatry 27:202-204, 2003.

322. Katz IR, Jeste DV, Pollock BG and Tariot PN: Commentary: Treating aggressive behavior in the elderly. Journal of Clinical Psychiatry 64:S12-S16, 2003.

323. Lindamer LA, Bailey A, Hawthorne W, Folsom D, Gilmer TP, Garcia P, Hough RL and Jeste DV: Gender differences in characteristics and service use of public mental health patients with schizophrenia. Psychiatric Services 54: 1407-1409, 2003.

324. Twamley EW, Jeste DV and Lehman, AF: Vocational rehabilitation in schizophrenia and other psychotic disorders: A literature review and meta-analysis of randomized controlled trials. The Journal of Nervous and Mental Disease 191:515-523, 2003.

325. Twamley EW, Jeste DV and Bellack AS: A review of cognitive training in schizophrenia. Schizophrenia Bulletin 29:359-382, 2003.

326. Cummings JL and Jeste DV: Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: Definitional and regulatory aspects. TEN: Trends in Evidence-based Neuropsychiatry 5:36-40, 2003.

327. Jeste DV and Palmer BW: The changing view of Alzheimer Disease. TEN: Trends in Evidence-based Neuropsychiatry 5:32-35, 2003.

328. Wetherell JL, Palmer BW, Thorp S, Patterson TL, Golshan S and Jeste DV: Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder. Journal of Clinical Psychiatry 23:1476-1482, 2003.

329. Jeste DV, Barak Y, Madhusoodanan S, Grossman F and Gharabawi G: An international multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 eldelry patients with chronic schizophrenia. American Journal of Geriatric Psychiatry 11:638-647, 2003.

330. Sciolla A, Patterson TL, McAdams LA, Wetherell J, Koch W, Jeste DV: Functioning and well-being of middle-aged and older patients with schizophrenia: Measurement with the 36-item short-form (SF-36) health survey. American Journal of Geriatric Psychiatry 11:629-637, 2003.

331. Jeste DV, Dunn LB, Palmer BW, Saks E, Halpain M, Cook A, Appelbaum P, and Schneiderman L: A collaborative model for research on decisional capacity and informed consent in older patients with schizophrenia: Bioethics Unit of a Geriatric Psychiatry Intervention Research Center. Psychopharmacology 171:68-74, 2003.

332. Dunn LB and Jeste DV: Problem areas in the understanding of informed consent for research: Study of middle-aged and older patients with psychotic disorders. Psychopharmacology 171:81-85, 2003.

333. Sweet RA, Nimgaonkar VL, Devlin B and Jeste DV: Psychotic symptoms in Alzheimer Disease: Evidence for a distinct phenotype. Molecular Psychiatry 8:383-392, 2003.

334. Sable JA and Jeste DV: Pharmacologic management of psychosis in the elderly. Journal of Nutrition, Health & Aging 7:421-427, 2003.

335. Gilmer TP, Folsom DP, Hawthorne W, Lindamer LA, Hough RL, Garcia P and Jeste DV: Assisted living and use of health services among Medicaid beneficiaries with schizophrenia. Journal of Mental Health Economics and Policy 6:59-65, 2003.

336. Chiu E and Jeste, D: Identifying knowledge gaps and research challenges in geriatric psychiatry. Current Opinion in Psychiatry 16:607-608, 2003.

337. Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand CP, Jeste DV, Krishnan KRR, Lyketsos CG, Lyness JM, Rabins PV, Reynolds CF, Rovner BW, Steffens DC, Tariot PN, Unutzer J and Lebowitz BD: Provisional diagnostic criteria for depression of Alzheimer Disease: Description and review. Expert Review of Neurotherapeutics 3: 99-106, 2003.

338. Jeste DV and Nasrallah HA: Schizophrenia and aging: No more dearth of data? (Editorial). American Journal of Geriatric Psychiatry 11:584-587, 2003.

339. Woo BKP, Daly JW, Allen EC, Jeste DV and Sewell DD: Unrecognized medical disorders in older psychiatric inpatients in a Senior Behavioral Health Unit in a University Hospital. Journal of Geriatric Psychiatry and Neurology 16:121-125; 2003.

340. Kennedy JS, Jeste DV, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, and Breier A: Olanzapine vs. haloperidol in geriatric schizophrenia: Analysis of data from a double-blind controlled trial. International Journal of Geriatric Psychiatry 18:1013-1020, 2003.

341. Jeste DV and Dolder CR: Treatment of non-schizophrenic disorders: Focus on atypical antipsychotics. Journal of Psychiatric Research 38:73-103, 2004.

342. Dolder CR, Patterson TL and Jeste DV: HIV, psychosis and aging: Past, present and future. AIDS 18:S35-S42, 2004.

343. Evans EA and Jeste DV: William Carlos Williams. American Journal of Geriatric Psychiatry 12:129-133, 2004.

344. Palmer BW, Dunn LB, Appelbaum PS and Jeste DV: Correlates of treatment-related decision making capacity among middle-aged and older patients with schizophrenia. Archives of General Psychiatry 61:230-236, 2004.

345. Wetherell JL, Thorp SR, Patterson TL, Golshan S, Jeste DV, Gatz M: Quality of life in geriatric generalized anxiety disorder: A preliminary investigation. Journal of Psychiatric Research 38: 305-312, 2004.

346. Gilmer TP, Dolder CR, Lacro JP, Folsom D, Lindamer L, Garcia P and Jeste DV: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161: 692-699, 2004.

347. Kindermann SS, Brown GG, Eyler Zorrilla L, Olsen RK and Jeste DV: Spatial working memory among middle-aged and older patients with schizophrenia and volunteers using fMRI. Schizophrenia Research 68:203-216, 2004.

348. Kim SYH, Appelbaum PS, Jeste DV and Olin J: Proxy and surrogate consent in geriatric neuropsychiatric research: Update and recommendations. American Journal of Psychiatry 161: 797-806, 2004.

349. Eyler LT, Olsen RK, Jeste DV and Brown GG: Abnormal brain response of chronic schizophrenia patients despite normal performance during a visual vigilance task. Psychiatry Research Neuroimaging 130: 245-257, 2004.

350. McKibbin C, Patterson TL and Jeste DV: Assessing disability in older patients with schizophrenia: Results from the WHODAS-II. Journal of Nervous and Mental Disease 192: 405-413, 2004.

351. Jeste DV: Tardive dyskinesia rates with atypical antipsychotics in older patients. Journal of Clinical Psychiatry 65: 21-24, 2004.

352. Dolder CR, Lacro JP, Warren KA, Golshan S, Perkins DO and Jeste DV: Brief Evaluation of Medication Influences and Beliefs (BEMIB): Development and testing of a brief scale for medication adherence. Journal of Clinical Psychopharmacology 24: 404-409, 2004.

353. Moore DJ, Palmer BW and Jeste DV: Use of Mini-Mental State Exam in middle-aged and older outpatients with schizophrenia: Cognitive impairment and its associations. American Journal of Geriatric Psychiatry 12: 412-419, 2004.

354. Jeste DV: Lifetime influence of one year with Gerry Smith. Physiology and Behavior 82: 167-170, 2004.

355. Auslander LA and Jeste DV: Sustained remission of schizophrenia among community-dwelling older outpatients. American Journal of Psychiatry 161:1490-1493, 2004.

356. Kinon BJ, Jeste DV, Kollack-Walker S, Stauffer V and Liu-Seifert H: Olanzapine treatment for tardive dyskinesia in schizophrenia patients: A prospective clinical trial with patients randomized to blinded dose reduction periods. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28:985-996, 2004.

357. Jeste ND, Palmer BW and Jeste DV: Historical Case Conference: Tennessee Williams. American Journal of Geriatric Psychiatry 12:370-375, 2004.

358. Jin H, Meyer JM, and Jeste DV: Atypical antipsychotics and glucose dysregulation: A systematic review. Schizophrenia Research 71:195-212, 2004.

359. Folsom DP, Nayak GV, and Jeste DV: Antipsychotic medications and the elderly. Primary Psychiatry 11: 47-50, 2004.

360. Depp CA and Jeste DV: Bipolar disorder in older adults: A critical review. Bipolar Disorders 6: 343-367, 2004.

361. Woo BKP, Rice VA, Legendre SA, Salmon DP, Jeste DV and Sewell DD: The clock drawing test as a measure of executive dysfunction in elderly depressed patients. Journal of Geriatric Psychiatry and Neurology, 17:190-294, 2004.

362. Caligiuri M and Jeste DV: Association of diabetes with dyskinesia in older psychosis patients. Psychopharmacology 176:281-286, 2004.

363. Depp CA, Jin H, Mohamed S, Kaskow J, Moore J, and Jeste DV: Bipolar disorder in middle aged and elderly adults: Is age of onset important? The Journal of Nervous and Mental Disease 192:796-799, 2004.

364. Pedrelli P, McQuaid JR, Granholm E, Patterson TL, McClure F, Beck AT, and Jeste DV: Measuring cognitive insight in middle-aged and older patients with psychotic disorders.
Schizophrenia Research 71:297-305, 2004.

365. Gladsjo JA, McAdams LA, Palmer BW, Moore D, Jeste DV, and Heaton RK: A six-factor model of cognition in schizophrenia and related psychotic disorders: Relationships with clinical symptoms and functional capacity. Schizophrenia Bulletin 30:739-754, 2004.

366. McKibbin CL, Brekke JS, Sires D, Jeste DV, and Patterson TL: Direct assessment of functional abilities: Relevance to persons with schizophrenia. Schizophrenia Research 72:53-67, 2005.

367. Folsom DP, Hawthorne W, Lindamer L, Gilmer T, Bailey A, Golshan S, Garcia P, Unutzer J, Hough R and Jeste DV: Prevalence and risk factors for homelessness and utilization of mental health services amont 10,340 patients with serious mental illness in a large public mental health system. American Journal of Psychiatry 162: 370-376, 2005.

368. Jeste DV: Feeling fine at hundred and three: Secrets of successful aging. American Journal of Preventive Medicine 28:323-324, 2005.

369. Halpain MC, Trinidad GI, Wetherell JL, Lebowitz BD and Jeste DV: Intensive short-term research training for undergraduate, graduate, and medical students: Early experience with a new national-level approach in geriatric mental health. Academic Psychiatry 29:58-65, 2005.

370. Martin JL, Jeste DV, and Ancoli-Israel S: Older schizophrenia patients have more disrupted sleep and circadian rhythms than age-matched comparison subjects. Journal of Psychiatric Research 39:251-259, 2005.

371. Jeste DV: Another milestone: The Journal goes monthly (Editorial). American Journal of Geriatric Psychiatry 13:1-2, 2005.

372. Dolder CR, Furtek K, Lacro JP, Jeste DV: Antihypertensive medication adherence and blood pressure control in patients with psychotic disorders compared to persons without psychiatric illness. Psychosomatics 46:135-141, 2005.

373. Granholm E, Periveliotis D, McQuaid JR, Auslander LA, McClure FS, Pedrelli P, Patterson T, and Jeste DV: A randomized controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry 162:520-529, 2005.

374. Eyler LT, Mirzakhanian H and Jeste DV: A preliminary study of interactive questioning methods to assess and improve understanding of informed consent amont patients with schizophrenia. Schizophrenia Research 75:193-198, 2005.

375. Depp CA, Lindamer LA, Folsom DP, Gilmer T, Hough RL, Garcia P, and Jeste DV: Differences in clinical features and mental health service use in bipolar disorder across the life span. American Journal of Geriatric Psychiatry 13:290-298, 2005.

376. Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R, Golshan S, and Jeste DV: Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: Comparison of a three-item questionnaire with a comprehensive standardized instrument. Archives of General Psychiatry 62:726-733, 2005.

377. Jeste DV, Blazer D, and First M: Aging-related diagnostic variations: Need for diagnostic criteria appropriate for elderly psychiatric patients. Biological Psychiatry 58:265-271, 2005.

378. Davis CE, Jeste DV, and Eyler LT: Review of longitudinal neuroimaging studies of drug treatments in patients with schizophrenia. Schizophrenia Research 78:45-60, 2005.

379. Twamley EW, Padin D, Bayne K, Narvaez J, Williams R and Jeste DV: Work rehabilitation for older people with schizophrenia: A comparison of three approaches. The Journal of Nervous and Mental Disease 193:596-601, 2005.

380. Jeste DV, Dolder CR, Nayak GV, and Salzman C: Atypical antipsychotics in elderly patients with dementia or schizophrenia: Review of recent literature. Harvard Review of Psychiatry 13:340-351, 2005.

381. Stroup S, Appelbaum P, Swartz M, Patel M, Davis S, Jeste DV, Kim S, Keefe R, Manschreck T, McEvoy J and Lieberman: Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. Schizophrenia Research 80:1-8, 2005.

382. De Deyn P, Jeste DV, Swanink R, Kostic D, and Breder C: Aripiprazole for the treatment of psychosis in patients with Alzheimer’s disease: A randomized, placebo-controlled study. Journal of Clinical Psychopharmacology 25:463-467, 2005.

383. Ropacki SA and Jeste DV: Epidemiology of and risk factors for psychosis of Alzheimer Disease: A review of 55 studies published from 1990 to 2003. American Journal of Psychiatry 162:2022-2030, 2005.

384. Van Critters AD, Pratt SI, Bartels SJ and Jeste DV: Evidence-based review of pharmacologic and nonpharmacologic treatments for older adults with schizophrenia. Psychiatric Clinics of North America 28:913-939, 2005.

385. Patterson TL, Bucardo J, McKibbin CL, Mausbach BT, Moore D, Barrio C, Goldman SR, and Jeste DV: Development and pilot testing of a new psychosocial intervention for older Latinos with chronic psychosis. Schizophrenia Bulletin 31:922-930, 2005.

386. Montross LP, Barrio C, Yamada A-M, Lindamer L, Golshan S, Garcia P, Fuentes D, Hough RL and Jeste DV: Tri-ethnic variations of co-morbid substance and alcohol use disorders in schizophrenia. Schizophrenia Research 79:297-305, 2005.

387. Jeste ND, Moore DJ, Goldman S, Bucardo J, Davila-Fraga W, Golshan S, Jeste DV, and Patterson TL: Predictors of everyday functioning among older Mexican-Americans vs. Anglo-Americans with schizophrenia. Journal of Clinical Psychiatry 66:1304-1311, 2005.

388. Palmer BW and Jeste DV: Relationship of individual cognitive abilities to specific components of decisional capacity among middle-aged and older patients with schizophrenia. Schizophrenia Bulletin 32:98-106, 2006.

389. Jeste DV, Depp CA, and Palmer BW: Magnitude of impairment in decisional capacity in people with schizophrenia compared to normal subjects: An overview. Schizophrenia Bulletin 32:121-128, 2006.

390. Jeste DV: Editorial: Entering the 14th year: The AJGP continues to grow. American Journal of Geriatric Psychiatry 14:1, 2006.

391. Depp C and Jeste DV: Definitions and predictors of successful aging: A comprehensive review of the literature. American Journal of Geriatric Psychiatry 14:6-20, 2006.

392. Montross LP, Depp C, Daly J, Reichstadt J, Golshan S, Moore D, Sitzer D, and Jeste, DV: Correlates of successful aging among community-dwelling older adults. American Journal of Geriatric Psychiatry 14:43-51, 2006.

393. Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV: The health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. Journal of Clinical Psychiatry 67:215-221, 2006.

394. Dunn LB, Palmer BW, Keehan M, Jeste DV, and Appelbaum PS: Assessment of therapeutic misconception in older schizophrenia patients using a brief instrument. American Journal of Psychiatry 163:500-506, 2006.

395. Nayak-Savla G, Moore DJ, Roesch SC, Heaton RK, Jeste DV and Palmer BW: An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: Use of mixed-model analyses. Schizophrenia Research 83:215-223, 2006.

396. Twamley ET, Narvaez JM, Sadek JR, Jeste DV, Grant I, and Heaton RK: Work-related abilities in schizophrenia and HIV infection. The Journal of Nervous and Mental Disease 194:268-274, 2006.

397. Jeste DV: Can medication-free research ever be ethical in older people with psychotic disorders? Schizophrenia Bulletin 32:303-304, 2006.

398. Mittal D, Davis CE, Depp C, Pyne JM, Golshan S, Patterson TL, Jeste DV: Correlates of health-related quality of well-being in older patients with schizophrenia. Journal of Nervous and Mental Disease 194:335-340, 2006.

399. Yamada AM, Barrio C, Morrison SW, Sewell D, Jeste DV: Cross-ethnic evaluation of psychotic symptom content in hospitalized middle-aged and older adults. General Hospital Psychiatry 28:161-8, 2006.

400. Kryzhanovskaya LA, Jeste DV, Young C, Polzer J, Roddy T, Jansen J, Carlson J, and Cavazzoni P: A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia. Journal of Clinical Psychiatry 67:933-945, 2006.

401. Yamada AM, Valle R, Barrio C and Jeste DV: Selecting an acculturation measure for use with Latino older adults. Research on Aging 28:519-561, 2006.

402. Sitzer DI, Twamley EW and Jeste DV: Cognitive training in Alzheimer disease: A metaanalysis of the literature. Acta Psychiatrica Scandinavica 114:75-90, 2006.

403. Saks ER and Jeste DV: Capacity to consent to or refuse treatment and/or research: Theoretical considerations. Behavioral Sciences and the Law 24:411-429, 2006.

404. Eyler LT and Jeste DV: Enhancing the informed consent process: A conceptual overview. Behavioral Sciences and the Law 24: 553–568, 2006.

405. Jeste DV and Saks ER: Decisional capacity in mental illness and substance use disorders: Empirical database and policy implications. Behavioral Sciences and the Law 24:607-628, 2006.

406. Dunn LB, Nowrangi MA, Palmer BW, Jeste DV, and Saks ER: Assessing decisional capacity for clinical research or treatment: A review of instruments. American Journal of Psychiatry 163:1323-1334, 2006.

407. Jeste DV, Meeks TW, Kim DS and Zubenko GS: Research agenda for DSM-V: Diagnostic categories and criteria for neuropsychiatry syndromes in dementia. Journal of Geriatric Psychiatry and Neurology 19:160-71, 2006.

408. Patterson TL, McKibbin C, Mausbach BT, Goldman S, Bucardo J and Jeste DV: Functional Adaptation Skills Training (FAST): A randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophrenia Research 86:291-299, 2006.

409. McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, Mudaliar S, Barrio C, O’Hanlon K, Griver K, Sirkin A, and Jeste DV: A lifestyle intervention for older schizophrenia patients with Diabetes Mellitus: A randomized controlled trial. Schizophrenia Research 86: 36-44, 2006.

410. Mohamed S, Bondi MW, Kasckow JW, Golshan S, and Jeste DV: Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia. International Journal of Geriatric Psychiatry 21:711-718, 2006.

411. Twamley EW, Palmer BW, Jeste DV and Heaton RK: Transient and executive function working memory in schizophrenia. Schizophrenia Research 87:185-190, 2006.

412. Meeks TW, Ropacki SA and Jeste DV: The neurobiology of neuropsychiatric syndromes in dementia. Current Opinion in Psychiatry 19:581-586, 2006.

413. Chiu E and Jeste DV: Efficacy and Cost-Effectiveness in dementia interventions – The need for an international consensus. Current Opinion in Psychiatry 19:553-554, 2006.

414. Haupt M, Cruz-Jentoft A, and Jeste DV: Mortality in elderly dementia patients treated with risperidone. Journal of Clinical Psychopharmacology 26:566-570, 2006.

415. Li C, Wu W, Jin H, Zhang X, Xue H, He Y, Xiao S, Jeste DV and Zhang M: Successful aging in Shanghai, China: Definition, distribution and related factors. International Psychogeriatrics 18:551-563, 2006.

416. Folsom DP, Lindamer L, Montross L, Hawthorne W, Golshan S, Hough R, Shale J, and Jeste DV: Diagnostic variability for schizophrenia and major depression in a large public mental healthcare system district. Psychiatry Research 144:167-175, 2006.

417. Gilmer T, Ojeda VD, Folsom D, Fuentes D, Garcia P and Jeste DV: Costs of community-based public mental health services for older adults: Variations related to age, ethnicity, and diagnosis. International Journal of Geriatric Psychiatry 21:1121-1126, 2006.

418. Moore DJ, Savla GN, Woods SP, Jeste DV, and Palmer BW: Verbal fluency impairments among community-dwelling, middle-aged and older adults with schizophrenia are characterized by deficient switching. Schizophrenia Research 87:254-260, 2006.

419. Woo BKP, Golshan S, Allen EC, Daly JW, Jeste DV and Sewell DD: Factors associated with frequent admissions to an acute geriatric psychiatric inpatient unit. Journal of Geriatric Psychiatry and Neurology 19:226-230, 2006.

420. Folsom DP, McKibbin C, Jeste DV, and Patterson T: Use of primary care by middle aged and older persons with schizophrenia. Primary Care and Community Psychiatry 11:101-106, 2006.

421. Woods SP, Twamley EW, Dawson MS, Narvaez JM and Jeste DV: Deficits in cue detection and intention retrieval underlie prospective memory impairment in schizophrenia. Schizophrenia Research 90:344-350, 2007.

422. Moore DJ, Palmer BW, Patterson TL and Jeste DV: A review of performance-based measures of functional living skills. Journal of Psychiatric Research 41:97-118, 2007.

423. Jeste DV, Halpain M, Trinidad G, Reichstadt J, and Lebowitz BD: UCSD’s short-term research training programs for trainees at different levels of career development. Academic Psychiatry 31:160-167, 2007.

424. Mittal D, Palmer BW, Dunn LB, Landes R, Ghormley C, Beck C, Golshan S, Blevins D, and Jeste DV: Comparison of two enhanced consent procedures for patients with mild Alzheimer Disease or mild cognitive impairment. American Journal of Geriatric Psychiatry 15:163-167, 2007.

425. Dunn LB, Palmer BW, Appelbaum PS, Saks ER, Aarons GA, and Jeste DV: Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia. Schizophrenia Research 89:110-118, 2007.

426. Reichstadt J, Depp CA, Palinkas LA, Folsom DP and Jeste DV: Building blocks of successful aging: A focus group study of older adults’ perceived contributors to successful aging. American Journal of Geriatric Psychiatry 15:194-201, 2007.

427. Palmer BW, Dunn LB, Depp C, Eyler LT, and Jeste DV: Decisional capacity to consent to research among patients with bipolar disorder: Comparison with schizophrenia patients and healthy subjects. Journal of Clinical Psychiatry 68:689-696, 2007.

428. Palinkas LA, Criado V, Fuentes D, Shepherd S, Milian H, Folsom D, and Jeste DV: Unmet needs for services for older adults with mental illness: Comparison of views of different stakeholder groups. American Journal of Geriatric Psychiatry 15:530-540, 2007.

429. Gilmer TP, Dolder CR, Folsom DP, Mastin W and Jeste DV: Antipsychotic polypharmacy trends Medi-Cal beneficiaries with schizophrenia in San Diego County, 1999–2004. Psychiatric Services 58:1007-1010, 2007.

430. Jeste DV, Palmer BW, Appelbaum PS, Golshan S, Glorioso D, Dunn LB, Kim K, Meeks T, Kraemer HC: A new brief instrument for assessing decisional capacity for clinical research. Archives of General Psychiatry 64:966-974, 2007.

431. Folsom DP, Gilmer T, Barrio C, Moore DJ, Bucardo J, Lindamer LA, Garcia P, Hawthorne W, Hough R, Patterson T, and Jeste DV: A longitudinal study of the use of mental health services by persons with serious mental illness: Spanish-speaking Latinos differ from English-speaking Latinos and Caucasians. American Journal of Psychiatry 164:1173-1180, 2007.

432. Glatt SJ, Chayavichitsilp P, Depp C, Schork NJ, and Jeste DV: Successful aging: From phenotype to genotype. Biological Psychiatry 62:282-293, 2007.

433. Jeste DV and Meeks T: To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia. Southern Medical Journal 100:961-3, 2007.

434. Meeks TW, Wetherell J, Irwin MR and Jeste DV: Complementary and alternative treatments for late-life depression, anxiety, and sleep disturbance: A review of randomized controlled trials. Journal of Clinical Psychiatry 68:1461-71, 2007.

435. Meeks TW and Jeste DV: Complementary and alternative medicine (CAM) use in geriatric psychiatry clinics. Journal of Alternative and Complementary Medicine 13:705-7, 2007.

436. Wetherell LJ, Kim DS, Lindamer LA, Thorp SR, Hawthorne W, Kim K, Hough RL, Garcia P and Jeste DV: Anxiety disorders in a public mental health system: Clinical characteristics and service use patterns.J Affect Disord 104:179-83, 2007.

437. Jeste DV, Dunn LB, Folsom DP, and Zisook D: Multimedia educational aids for improving consumer knowledge about illness management and treatment decisions: A review of randomized controlled trials. Journal of Psychiatric Research 42:1-21, 2007.

438. Moore DJ, Sitzer D, Depp CA, Montross LP, Reichstadt J, Lebowitz BD and Jeste DV: Self-administered cognitive screening of a community-dwelling successfully aging cohort. International Journal of Geriatric Psychiatry 22:327-31, 2007.

439. Depp CA, Moore DJ, Sitzer D, Palmer BW, Lebowitz BD, Eyler LT, Roesch S, and Jeste DV: Neurocognitive impairment in middle-aged and elderly adults with bipolar disorder: Comparison to schizophrenia and normal comparison subjects. Journal of Affective Disorders 101:201-9, 2007.

440. Mausbach BT, Harvey PD, Goldman S, Jeste DV and Patterson TL: Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophrenia Bulletin 33:1364-72, 2007.

441. Eyler LT, Olsen RK, Nayak GV, Mirzakhanian H, Brown GG, and Jeste DV: Brain response correlates of decisional capacity in schizophrenia: a preliminary FMRI study. Journal of Neuropsychiatry and Clinical Neuroscience 19:137-44, 2007.

442. Depp CA, Lebowitz BD, Patterson TL, Lacro JP, and Jeste DV: Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: Development and pilot study. Bipolar Disorders 9:636-45, 2007.

443. Granholm E, McQuaid JR, McClure FS, Link P, Perivoliotis D, Gottlieb JD, Patterson T and Jeste DV: Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry 68:730-7, 2007.

444. Kim SYH, Appelbaum PS, Swan J, Stroup TS, McEvoy JP, Goff DC, Jeste DV, Lamberti JS, Leibovici A and Caine ED: Determining when impairment constitutes incapacity for informed consent in schizophrenia research. British Journal of Psychiatry 191:38-43, 2007.

445. Depp C, Glatt SJ and Jeste DV: Recent advances in research on successful or healthy aging. Current Psychiatry Reports 9:7-13, 2007.

446. Chiu E and Jeste DV: Publication of the International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. Current Opinion in Psychiatry 20:531-532, 2007.

447. Gilmer T, Ojeda V, Folsom D, Fuentes D, Garcia P and Jeste DV: Initiation and use of public mental health services by persons with severe mental illness and limited english proficiency. Psychiatric Services 58:1555-1562, 2007.

448. Mausbach BT, Budardo J, McKibbin CL, Cardenas V and Barrio C: Evaluation of a culturally tailored skills intervention for Latinos with persistent psychotic disorders. American Journal of Psychiatric Rehabilitation 11:61-75, 2008.

449. Eyler LT, Jeste DV and Brown GG: Brain response abnormalities during verbal learning among patients with schizophrenia. Psychiatry Research: Neuroimaging 162:11-25, 2008.

450. Jin H, Meyer JM, Mudaliar S and Jeste DV: Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophrenia Research 100:70-85, 2008.

451. Granholm E, McQuaid JR, Link, PC, Fish S, Patterson T and Jeste DV: Neuropsychological predictors of functional outcome in cognitive behavioral social skills training for older people with schizophrenia. Schizophrenia Research 100:133-143, 2008.

452. Mausbach BT, Cardenas V, McKibbin CL, Jeste DV and Patterson TL: Reducing emergency medical service use in patients with chronic psychotic disorders: results from the FAST intervention study. Behaviour Research and Therapy 46:145-153, 2008.

453. Twamley, EW, Narvaez, JM, Becker, DR, Bartels, SJ, & Jeste, DV: Supported employment for middle-aged and older people with schizophrenia. American Journal of Psychiatric Rehabilitation 11:76-89, 2008.

454. Lindamer LA, Lebowitz BD, Hough RL, Garcia P, Aquirre A, Halpain MC, Depp C and Jeste DV: Improving care for older persons with schizophrenia through an Academic-Community Partnership. Psychiatric Services 59:236-239, 2008.

455. Mausbach BT, Bowie CR, Harvey PD, Twamley EW, Goldman SR, Jeste DV and Patterson TL: Usefulness of the UCSD Performance-based Assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. Journal of Psychiatric Research 42:320-327, 2008.

456. Jeste DV, Blazer D, Casey DE, Meeks T, Salzman C, Schneider L, Tariot P and Yaffe K: ACNP White Paper: Update on the use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 33:957-970, 2008.

457. Twamley EW, Savla GN, Zurhellen CH, Heaton RK, and Jeste DV: Development and pilot testing of a novel compensatory cognitive training intervention for people with psychosis. American Journal of Psychiatric Rehabilitation 11:144-163, 2008.

458. Dawes SE, Palmer BW and Jeste DV: Adjudicative competence. Current Opinion in Psychiatry 21:490-4, 2008.

459. Sitzer DI, Twamley EW, Patterson TL, and Jeste DV: Multivariate predictors of social skills performance in middle-aged and older outpatients with schizophrenia spectrum disorders. Psychological Medicine 38:755-63, 2008.

460. Barrio C, Garcia P, Palinkas LA, Yamada A-M, Fuentes D, Criado V and Jeste DV: Unmet needs for mental health services for Latino older adults: Perspectives from consumers, family members, advocates, and service providers. Community Mental Health Journal 44:57-74, 2008.

461. Delano-Wood L, Houston WS, Emond JA, Marchant NL, Salmon DP, Jeste DV, Thal LJ, and Bondi MW: APOE genotype predicts depression in women with Alzheimer’s disease: A retrospective study. International Journal of Geriatric Psychiatry 23:632-6, 2008.

462. Irwin SA, Zurhellen CH, Diamond LC, Dunn LB, Palmer BW, Jeste DV and Twamley EW: Unrecognized cognitive impairment in hospice patients: a pilot study. Palliative Medicine 22:842-847, 2008.

463. Twamley EW, Woods SP, Zurhellen CH, Vertinski M, Narvaez JM, Mausbach BT, Patterson TL and Jeste DV: Neuropsychological substrates and everyday functioning implications of prospective memory impairment in schizophrenia. Schizophrenia Research 106:42-49, 2008.

464. Jeste DV and Vahia I: Comparison of the conceptualization of wisdom in ancient Indian literature with modern views: Focus on the Bhagavad Gita. Psychiatry 71:197-209, 2008.

465. Meeks TW and Jeste DV: Beyond the black box: What is the role for antipsychotics in dementia. Current Psychiatry 7:50-65, 2008.

466. Bucardo J, Patterson TL and Jeste DV: Cultural formulation with attention to language and cultural dynamics in a Mexican psychiatric patient treated in San Diego, USA. Culture, Medicine, and Psychiatry 32:102-21 2008.

467. Lamond AJ, Depp C, Allison M, Langer R, Reichstadt J, Moore DJ, Golshan S, Ganiats TG and Jeste DV: Measurement and predictors of resilience among community-dwelling older women. Journal of Psychiatric Research 43:148-54, 2008.

468. Salzman C, Jeste DV, Meyer RE, Cohen-Mansfield J, Cummings J, Grossberg G, Jarvik L, Kraemer H, Lebowitz B, Maslow K, Pollock B, Raskind M, Schultz S, Wang P, Zito JM and Zubenko GS: Elderly patients with dementia-related symptoms of severe agitation and aggression: Consensus statement on treatment options, clinical trials methodology, and policy. Journal of Clincial Psychiatry 69:889-98, 2008.

469. Depp CA, Savla GN, Moore DJ, Palmer BW, Stricker JL, Lebowitz BD and Jeste DV: Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder. Bipolar Disorder 10:684-90, 2008.

470. McKibbin CL, Trenova-Oliver L, Golshan S, Patterson TL, Lebowitz B, Shepherd S and Jeste DV: Perceived participation restriction in middle-aged and older persons with schizophrenia. American Journal of Geriatric Psychiatry 16:777-80, 2008.

471. Depp C, Cain AE, Palmer BW, Moore DJ, Eyler LT, Lebowitz BD, Patterson TL and Jeste DV: Assessment of medical management ability in later life bipolar disorder. Journal of Clinical Psychopharmacology 28:225-9, 2008.

472. Eyler LT, Kaup AR, Mirzakanian H and Jeste DV: Schizophrenia patients lack normal positive correlation between age and brain response during verbal learning. American Journal of Geriatric Psychiatry 17:43-55, 2009.

473. Lanouette NM, Folsom DP, Sciolla A and Jeste DV: Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review. Psychiatric Services 60:157-174, 2009.

474. Henry J, Palmer BW, Palinkas L, Glorioso DK and Jeste DV: Reformed consent: adapting to new media and research participant preferences. IRB: Ethics and Human Research 31:1-8, 2009.

475. Lindamer LA, Lebowitz B, Hough RL, Garcia P, Aguirre A, Halpain MC, Depp C and Jeste DV: Establishing an implementation network: lessons learned from community-based participatory research. Implementation Science 4:17, 2009.

476. Meeks TW and Jeste DV: Neurobiology of wisdom: An overview. Archives of General Psychiatry 66:355-365, 2009.

477. Jeste DV, Twamley EW, Cardenas V, Lebowitz B and Reynolds CF: A call for training the trainers: Focus on mentoring to enhance diversity in mental health research. American Journal of Public Health 99:S31-S37, 2009.

478. Meeks TW, Lanouette N, Vahia I, Dawes S, Jeste DV and Lebowitz B: Psychiatric assessment and diagnosis in older adults. Focus 7:3-16, 2009.

479. Jin H, Lanouette NM, Mudaliar S, Henry R, Folsom DP, Khandrika S, Glorioso DK and Jeste DV: Association of post-traumatic stress disorder with increased prevalence of metabolic syndrome. Journal of Clinical Psychopharmacology 29:210-215, 2009.

480. Jeste DV, Palmer BW, Golshan S, Eyler LT, Dunn LB, Meeks T, Glorioso D, Fellows I, Kraemer H and Appelbaum PS: Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial. Schizophrenia Bulletin 35:719-29, 2009.

481. Zisook S, Kasckow J, Golshan S, Fellows I, Solorzano E, Lehman D, Mohamed S and Jeste DV: Citalopram augmentation for subsyndromal depressive symptoms in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: A randomized controlled trial. Journal of Clinical Psychiatry 70:562-71, 2009.

482. Depp CA, Stricker JL, Zagorsky D, Goodale LC, Eyler LT, Patterson TL, Lebowitz BD and Jeste DV: Disability and self-management practices of people with bipolar disorder: A web-based survey. Community Mental Health Journal 45:179-87, 2009.

483. Folsom DP, Depp C, Palmer BW, Mausbach BT, Golshan S, Fellows I, Cardenas V, Patterson TL, Kraemer HC and Jeste DV: Physical and mental health-related quality of life among older people with schizophrenia. Schizophrenia Research 108:207-13, 2009.

484. Cain AE, Depp C and Jeste DV: Ecological momentary assessment in aging research: a critical review. Journal of Psychiatric Research 43:987-96, 2009.

485. Jeste DV, Jin H, Golshan S, Mudaliar S, Glorioso D, Fellows I, Kraemer H and Arndt S: Letter to the Editor: Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events. American Journal of Psychiatry 166:937-938, 2009.

486. Essock SM, Covell NH, Leckman-Westin E, Lieberman J, Sederer L, Kealey E, Finnerty M, and Members of the Scientific Advisory Committee (Bartels SJ, Buchanan RW, Buckley PF, Calabrese JR, Conley RR, Dixon L, Emslie GJ, Findling RL, Frazier JA, Goff DC, Greenhill L, Jeste DV, Kane JM, Marder SR, Meyers BS, Miller AL, Nierenberg AA, Olfson M, Roose SP, Schneider LS, Schooler NR, Shear MK, Stein B, Stroup TS, Thase ME, Wagner KD, Wisner KL, Deegan PE, Pat Deegan PhD & Associates, LLC, Drake RE, Hoagwood K): Identifying Clinically Questionable Psychotropic Prescribing Practices and Their Prevalence among Medicaid Recipients in New York State. Psychiatric Services 60:1595-1602, 2009.

487. Emmerson LC, Ben-Zeev D, Granholm E, Tiffany M, Golshan S and Jeste DV: Prevalence and longitudinal stability of negative symptoms in healthy participants. International Journal of Geriatric Psychiatry 24:1438-44, 2009.

488. Depp CA, Mausbach BT, Eyler LT, Palmer BW, Cain AE, Lebowitz BD, Patterson TL and Jeste DV: Performance-based and subjective measures of functioning in middle-aged and older adults with bipolar disorder. Journal of Nervous and Mental Disease 197:471-475, 2009.

489. Mittal D, Owen RR, Lacro JP, Landes RD, Edlund M, Valenstein M and Jeste DV: Antipsychotic adherence intervention for veterans over 40 with schizophrenia: Results of a pilot study. Clinical Schizophrenia and Related Psychosis 24:S1171, 2009.

490. Emmerson LC, Granholm E, Link PC, McQuaid, JR and Jeste DV: Insight and treatment outcome with cognitive behavioral social skills training for older people with schizophrenia. Journal of Rehabilitation Research and Development 46:1053-1058, 2009.

491. Jeste DV and Depp CA: Editorial: Positive mental aging. American Journal of Geriatric Psychiatry 18:1-3, 2010.

492. Young JW, Powell SB, Gayer MA, Jeste DV, and Risbrough V: The mouse attentional set-shifting task: A method for assaying successful cognitive aging? Cognitive, Affective, & Behavioral Neuroscience 10: 243-251, 2010.

493. Jeste DV, Depp CA, and Ipsit V: Succesful cognitive and emotional aging. World Psychiatry 9: 78-84, 2010.

494. Vahia IV, Meeks TW, Thompson WK, Depp CA, Zisook S, Allison M, Judd LL and Jeste DV: Subthreshold depression and successful aging in older women. American Journal of Geriatric Psychiatry 18: 212-220, 2010.

495. Rosenberg D, Depp CA, Vahia IV, Reichstadt J, Palmer BW, Kerr J, Norman G and Jeste DV: Exergames for subsyndromal depression in older adults: A pilot study of a novel intervention. American Journal of Geriatric Psychiatry 18: 221-226, 2010.

496. Reichstadt J, Sengupta G, Depp CA, Palinkas LA, and Jeste DV: Older adults’ perspectives on successful aging: Qualitative interviews. American Journal of Geriatric Psychiatry 18:567-75, 2010.

497. Soontomniyomkij V, Risbrough VB, Young JW, Wallace CK, Soontomniyomkij B, Jeste DV, and Achim CL: Short-term recognition memory impairment is associated with decreased expression of FK506 binding protein 51 in the aged mouse brain. AGE: Journal of American Aging Association 32:309–322, 2010.

498. Bangen KJ, Delano-Wood L, Wierenga CE, McCauley A, Jeste DV, Salmon DP, Bondi MW: Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression. Int J Geriatr Psychiatry. 25:175-182, 2010.

499. Depp CA, Schkade DA, Thompson WK and Jeste DV: Age, affective experience and television use. American Journal of Preventive Medicine 39:173-178, 2010.

500. Palmer BW, Savla GN, Fellows IE, Twamley EW, Jeste DV and Lacro JP: Do people with schizophrenia have differential impairment in episodic memory and/or working memory relative to other cognitive abilities? Schizophrenia Research 116:259-265, 2010.

501. Jeste DV, Ardelt M, Blazer D, Kraemer HC, Vaillant G, and Meeks T: Expert consensus on the characteristics of wisdom: A Delphi Method study. The Gerontologist 2010 Mar 15; [Epub ahead of print].

502. Vahia IV, Palmer BW, Depp C, Fellows I, Golshan S, Kraemer HC, and Jeste DV: Late-onset schizophrenia: A subtype of schizophrenia? Acta Psychiatrica Scandinavica 2010 March 20; [Epub ahead of print].

503. Shepherd S, Depp CA, Harris G, Halpain M, Palinkas LA, and Jeste DV: Perspectives on schizophrenia over the lifespan: A qualitative study. Schizophrenia Bulletin 2010 Jul 5; [Epub ahead of print].

504. Jin H, Meyer J, Mudaliar S, Henry R, Khandrika S, Glorioso DK, Kraemer H and Jeste DV: Use of clinical markers to identify metabolic syndrome in antipsychotic-treated patients. Journal of Clinical Psychiatry (in press, 2010).

505. Finkel SI and Jeste DV: Gene Cohen: The founding editor of the AJGP (1944-2009). American Journal of Geriatric Psychiatry (in press, 2010).

506. Kaup AR, Mirzakhanian H, Jeste DV, and Eyler LT: A review of the brain structure correlates of successful cognitive aging. Journal of Neuropsychiatry and Clinical Neurosciences (in press, 2010).

507. Dimsdale JE, Jeste DV, and Patterson TL: Beyond the global assessment of functioning: learning from Virginia Apgar. Psychosomatics (in press, 2010).

508. Granholm E, Link P, Fish S, Kraemer H and Jeste DV: Age-related practice effects across longitudinal neuropsychological assessments in older people with schizophrenia. Neuropsychology (in press, 2010).

509. Vahia IV, Depp CA, Palmer BW, Fellows I, Golshan S, Thompson W, Allison M, and Jeste DV: Correlates of spirituality in older women. Aging and Mental Health (in press, 2010).

510. Depp CA, Mausbach B, Granholm E, Cardenas V, Ben-Zeev D, Patterson TL, Lebowitz BD, and Jeste DV: Mobile interventions for severe mental illness: Design and preliminary data from three approaches. Journal of Nervous and Mental Disease (in press, 2010).

511. Watson LC, Lewis CL, Moore C, and Jeste DV: Perceptions of depression among dementia caregivers: Findings from the CATIE-AD trial. International Journal of Geriatric Psychiatry (in press, 2010).

512. Jeste DV and Harris JC: Commentary: Wisdom - A neuroscience perspective. Journal of the American Medical Association (in press, 2010).

513. Tiznado D, Mausbach B, Cardenas V, Jeste DV and Patterson T: UCSD SORT Test (U-SORT): Examination of a newly developed organizational skills assessment tool for severely mentally ill adults. Journal of Nervous and Mental Disease (in press, 2010).

514. Thorp SR, Sones HM, Glorioso D, Thompson W, Light GA, Golshan S and Jeste DV: Older patients with schizophrenia: Does military veteran status matter? American Journal of Geriatric Psychiatry (in press, 2010).

515. Meyers BS and Jeste DV: Geriatric Psychopharmacology: Evolution of a discipline. Journal of Clinical Psychiatry (in press, 2010).

516. Meeks T, Vahia I, Lavretsky H, Kulkarni G and Jeste DV: A Tune in “A Minor” Can “B Major”: A review of epidemiology, illness course, and public health implications of subthreshold depression in older adults. Journal of Affective Disorders (in press, 2010).

517. Dawes SE, Palmer BW, Allison MA, Ganiats TG, and Jeste DV: Social desirability does not confound reports of well-being or demographics by older women. Ageing and Society (in press, 2010).

518. Ali SS, Young J, Wallace C, Gresack J, Jeste DV, Geyer M, Dugan L and Risbrough V: Excess synaptic superoxide production predicts cognitive deficits in aged mice. Aging Cell (submitted, 2009).

519. Yamada A-M, Barrio C, Auslander LA, Hough R, Golshan S and Jeste DV: Treatment goal preferences among Latino older adults with psychotic disorders. Social Psychiatry and Epidemiology (submitted, 2009).

520. Pedrelli P, McQuaid JR, Golshan S, and Jeste DV: Stress, cognitive style, and depressive symptoms in patients with schizophrenia. Psychiatric Research (submitted, 2009).

521. Kavirajan H, Vahia IV, Thompson WK, Depp C, Allison M and Jeste DV: Correlates of attitude toward own aging in post-menopausal women. Journal of Geriatric Psychiatry and Neurology (submitted, 2010).

522. Fuentes D, Palinkas LA, Criado V, Garcia P, Shepherd S and Jeste DV: Social isolation and mental health of older adults. Journal of Psychology and Aging (submitted, 2010).

523. Eyler LT, Sherzai A and Jeste DV: A review of functional brain imaging correlates of successful cognitive aging. Biological Psychiatry (submitted, 2010).

524. Herrera AP, Meeks TW, Applewhite SR, Hernandez DM, Depp C, Tiznado D, Fuller-Iglesias H, Palinkas LA, Sommerfeld D and Jeste DV: Emotional health and quality of life in older age: Cultural perspectives from Mexican-Americans. Journal of Cross-Cultural Gerontology (submitted, 2010).

525. Lindamer A, Liu L, Sommerfeld D, Folsom DP, Hawthorne W, Garcia P, Aarons GA and Jeste DV: Predisposing, enabling, and need factors associated with high service use in a public mental health system. Administration and Policy in Mental Health (submitted, 2010).

526. Ganguli M, Blacker D, Blazer DG, Grant I, Jeste DV, Paulsen JS, Petersen RC and Sachdev PS: Classification of neurocognitive disorders in DSM-V. American Journal of Geriatric Psychiatry (submitted, 2010).

527. Jin H, Folsom D, Sasaki A, Mudaliar S, Henry R, Torres M, Golshan S, Glorioso DK and Jeste DV: Increased Framingham 10-year risk of coronary heart disease in older patients with psychosis. Schizophrenia Research (submitted, 2010).

528. Kaup AR, Dunn LB, Saks ER, Jeste DV and Palmer BW: Decisional capacity to consent to research in schizophrenia: An examination of errors. IRB: Ethics & Human Research (submitted, 2010).

529. Savla GN, Twamley EW, Thompson WK, Delis DC, Jeste DV and Palmer BW: Evaluation of specific executive functioning skills and the processes underlying executive control in schizophrenia. Journal of the International Neuropsychological Society (submitted, 2010).

530. Savla GN, Twamley EW, Delis DC, Roesch S, Jeste DV and Palmer BW: Dimensions of executive functioning in schizophrenia and their relationship with processing speed. Schizophrenia Bulletin (submitted, 2010).

531. Cahn BR and Jeste DV: Effects of meditation-based interventions in older adults: Review of randomized controlled trials. Journal of Clinical Psychiatry (submitted, 2010).

532. Dawes SE, Jeste DV and Palmer BW: Cognitive profiles in persons with chronic schizophrenia. Journal of Clinical and Experimental Neuropsychology (submitted, 2010).

Invited Book Chapters

1. Vahia NS, Doongaji DR and Jeste DV: Psychological medicine. In: Textbook of Medicine. Second Edition. Vakil RJ (ed). Bombay: Association of Physicians of India, 1973, pp. 1476 1498.

2. Vahia NS, Doongaji DR and Jeste DV: Value of Patanjali's concepts in the treatment of Psychoneurosis. In: New Dimensions in Psychiatry: A World View. S Arieti and G Chrzanowski (eds). New York: John Wiley and Sons. pp. 293-304, 1975.

3. Rosenblatt JE, Pary RJ, Bigelow LB, DeLisi LE, Wagner RL, Kleinman JE, Weinberger DR, Potkin SG, Shiling D, Jeste DV, Alexander P and Wyatt RJ: Measurement of serum neuroleptic concentrations by radioreceptor assay: Concurrent assessment of clinical response and toxicity. In: Neuroreceptors Basic and Clinical Aspects. E Usdin, WE Bunney and JM Davis (eds). New York: John Wiley and Sons, Ltd. pp. 165-188, 1981.

4. Potkin SG, Jeste DV, Karoum F, Doongaji DR, Apte JS, Sheth AS, Chuang L W and Wyatt RJ: A cross cultural design to test a biological hypothesis of schizophrenia. In: Biological Markers in Psychiatry and Neurology. E Usdin and I Hanin (ed). New York: Pergamon Press. pp. 49 59, 1982.

5. Wyatt RJ, Cutler NR, DeLisi LE, Jeste DV, Kleinman JE, Luchins DJ, Potkin SG and Weinberger DR: Biochemical and morphological aspects of schizophrenia. In: APA Annual Review. L Grinspoon (ed). Washington, DC: American Psychiatric Press. pp. 112 153, 1982.

6. Jeste DV, Jeste SD and Wyatt RJ: Reversible tardive dyskinesia: Implications for therapeutic strategy and prevention of tardive dyskinesia. In: New Directions in Tardive Dyskinesia Research. J Bannet and RH Belmaker (eds). Basel: S Karger. pp. 34 48, 1983.

7. Jeste DV and Wyatt RJ: Neuroleptic induced tardive dyskinesia. In: New Psychiatric Syndrome: DSM III and Beyond. S Akhtar (ed). New York: Jason Aronson, Inc. pp.313 338, 1983.

8. Jeste DV, Karson CN and Wyatt RJ: Movement disorder and psychopathology. In: Neuropsychiatric Movement Disorders. Jeste DV and Wyatt RJ (eds). Washington, DC: American Psychiatric Press. pp.119-150, 1984.

9. Jeste DV, Grebb J and Wyatt RJ: Psychiatric aspects of movement disorders and demyelinating diseases. In: Psychiatry Update, Vol. 4. AJ Frances and RE Hales (eds). Washington, DC: American Psychiatric Press. pp.159 189, 1985.

10. Jeste DV, Wisniewski A and Wyatt RJ: Neuroleptic associated "tardive" syndromes. In: Schizophrenia: The Psychiatric Clinics of North America. A Roy (ed). New York: Plenum Press. Vol. 9:1:183 192, 1986.

11. Jeste DV, Kaufmann CA and Wyatt RJ: Tardive dyskinesia and subtyping of schizophrenia. In: Movement Disorders. NS Shah and A Donald (eds). New York: Plenum Publishing Corporation. pp. 149 157, 1986.

12. Lohr J, Wisniewski A and Jeste DV: Neurological aspects of tardive dyskinesia. In: The Neurology of Schizophrenia. HA Nasrallah and DR Weinberger (eds). Amsterdam: Elsevier Science Publishers. pp. 97 119, 1986.

13. Jeste DV, Lohr JB, Mani RB, Cadel JL and Ludwig C: Neuronal loss in normal aging and neuropsychiatric dementias. In: Neuropsychiatric Dementias: Current Perspectives. DV Jeste (ed). Washington, DC: American Psychiatric Press. pp. 111-143, 1986.

14. Jeste DV, Lohr JB, Kaufmann CA and Wyatt RJ: Pathophysiology of tardive dyskinesia: Evaluation of supersensitivity theory and alternative hypotheses. In: Tardive Dyskinesia: From Dogma to Reason. D Casey and G Gardos (eds). Washington, DC: American Psychiatric Press. pp. 15-32, 1986.

15. Jeste DV, Lohr JB and Mani R: Quantitative neuropathology and aging. In: Biological Psychiatry 1985. C Shagass, RC Josiassen, WH Bridger, KJ Weiss, D Stoff and GM Simpson (eds.). New York: Elsevier Science Publishers, pp. 1409-1411, 1986.

16. Lohr JB and Jeste DV: Studies of cerebellum and hippocampus in major psychiatric disorders. In: Biological Psychiatry 1985. C Shagass, RC Josiassen, WH Bridger, KJ Weiss, D Stoff and GM Simpson (eds). New York: Elsevier Science Publishers, pp. 1024-1026, 1986.

17. Jeste DV, Lohr JB, Cadet JL and Wyatt RJ: Tardive dyskinesia: Neurological mechanisms. In: Biological Psychiatry 1985. C Shagass, RC Josiassen, WH Bridger, KJ Weiss, D Stoff and GM Simpson (eds.). New York: Elsevier Science Publishers, pp. 1205-1207, 1986.

18. Jeste DV, Iager A and Wyatt RJ: Biologic and therapeutic aspects of tardive dyskinesia and related movement disorders. In: American Handbook of Psychiatry, Vol. 8. PA Berger and HK Brodie (eds). New York: Basic Books. pp. 536-580, 1986.

19. Jeste DV and Lohr JB: Behavioral genetics. In: Behavioral Science. G Wiener (ed). New York: John Wiley and Sons, pp. 63-70, 1987.

20. Lohr JB, Kaufmann CA and Jeste DV: Biochemistry of behavior. In: Behavioral Science. G Wiener (ed). New York: John Wiley and Sons, pp. 13-26, 1987.

21. Jeste DV and Wyatt RJ: Aging and tardive dyskinesia. In: Schizophrenia and Aging: Schizophrenia, Paranoid and Schizophreniform Disorders in Later Life. NE Miller and GD Cohen (eds). New York: Guilford Press. pp. 275-286, 1987.

22. Weinberger DR, Jeste DV, Wyatt RJ and Teychenne PF: Cerebral atrophy in elderly schizophrenic patients: Effects of aging and of long-term institutionalization and neuroleptic therapy. In: Schizophrenia and Aging: Schizophrenia, Paranoid and Schizophreniform Disorders in Later Life. NE Miller and GD Cohen (eds). New York: Guilford Press. pp 109-118, 1987.

23. Cadet JL, Lohr JB and Jeste DV: Tardive dyskinesia and schizophrenic burnout: The possible involvement of cytotoxic free radicals. In: Handbook of Schizophrenia. Vol. 2: The Neurochemistry and Pharmacology of Schizophrenia. FA Henns and LE DeLisi (eds). Amsterdam: Elsevier Science Publishers. Chapter 15, 1987.

24. Carpenter WT, Schooler NR, Goldman H, Goldstein MJ, Hogarty GE, Jeste DV, Kane JM, Klerman GL, Liberman RP, Paul SM, Spring B, Stahl SM, Tamminga CA, Robinson DS: Relieving the pain: Research on treatment, services, and environmental factors. In: National Institute of Mental Health: Report to the National Advisory Mental Health Council on a National Plan for Research on Schizophrenia. Washington, DC: US Department of Health and Human Services, 1987, pp. 52-59.

25. Jeste DV, Harris MJ and Zweifach M: Late-onset schizophrenia. In: Psychiatry, Revised edition. R Michels, JO Cavenar, Jr, NKH Brodie, AM Cooper, SB Guze, LL Judd, GL Klerman, AJ Solnit (eds). Philadelphia: JB Lippincott Co., 1988, Chapter 56, pp. 1-8.

26. Lohr, JB and Jeste, DV: Neuroleptic-induced movement disorders: Acute and subacute disorders. In: Psychiatry, Revised edition. R Michels, JO Cavenar, Jr, NKH Brodie, AM Cooper, SB Guze, LL Judd, GL Klerman, AJ Solnit (eds). Philadelphia: JB Lippincott Co., 1988. Chapter 69, pp. 1-19.

27. Lohr, JB and Jeste, DV: Neuroleptic-induced movement disorders: Tardive dyskinesia and other tardive syndromes. In: Psychiatry, Revised edition. R Michels, JO Cavenar, Jr, NKH Brodie, AM Cooper, SB Guze, LL Judd, GL Klerman, AJ Solnit (eds). Philadelphia: JB Lippincott Co., 1988. Chapter 70, pp. 1-17.

28. Gierz M, Zweifach M and Jeste DV: Antidepressant agents. In: Alzheimer's Disease: Treatment and Long-term Management. JL Cummings and BL Miller (eds). New York: Marcel Dekker, Inc, 1990, pp. 125-141.

29. Phillipson M, Moranville JT, Jeste DV and Harris MJ: Antipsychotics. In: "Clinical Pharmacology" issue of "Clinics in Geriatric Medicine" Peter P Lamy (ed). Philadelphia: WB Saunders Company, 1990, pp 411-422.

30. Lohr JB, Manley MS, Kaufmann CA and Jeste DV: Neurochemistry. In: Behavioral Sciences, Second Edition, JM Wiener (ed.). Baltimore: Williams and Wilkins, 1990, pp. 1-21.

31. Jeste DV, Lohr JB and Kelsoe JM: Genetics of Behavioral Disorders. In: Behavioral Sciences, Second Edition, JM Wiener (ed.). Baltimore: Williams and Wilkins, 1990, pp. 57-70

32. Jeste DV: Neuroleptic treatment of chronically mentally ill elderly: Suggestions for future research. In: The Elderly With Mental Illness. E Light and B Lebowitz (eds). New York: Springer, 1991, pp. 133-144.

33. Sewell DD and Jeste DV: Neuroleptic Malignant Syndrome: Clinical Presentation, Pathophysiology, and Treatment. In: Medical Psychiatric Practice (Volume I). A Stoudemire and BS Fogel (eds). Washington, DC: American Psychiatric Press, 1991, pp. 425-452.

34. Dupont RM and Jeste DV: Conclusion. In: Brain Imaging in Affective Disorders. Hauser P (ed). Washington, DC: American Psychiatric Press, Inc., 1991, pp. 137-142.

35. McAdams LA and Jeste DV: Statistical methods in studies of chronically mentally ill elderly. In: The Elderly with Chronic Mental Illness. E Light and B Lebowitz (eds). New York: Springer, 1991, pp. 321-333.

36. Yassa R, Uhr S and Jeste DV: Gender differences in chronic schizophrenia: Need for further research. In: The Elderly with Chronic Mental Illness. E Light and B Lebowitz (eds). New York: Springer, 1991, pp. 16-31.

37. Jeste, DV, Manley, M and Harris, MJ: Psychoses. In: Comprehensive Review of Geriatric Psychiatry. J Sadavoy, L Lazarus, L Jarvik (eds). Washington, DC: American Psychiatric Press, 1991, pp. 353-368.

38. Lohr JB, Jeste DV, Harris MJ and Salzman C: Treatment of disordered behavior. In: Clinical Geriatric Psychopharmacology, second edition. C Salzman (ed). Published by Williams and Wilkins, 1992, pp. 79-113.

39. Tran-Johnson TK, Krull AJ and Jeste DV: Late-life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients. In Clinics in Geriatric Medicine. GS Alexopoulos (ed). Philadelphia, W.B. Saunders Company. 1992, pp. 401-410.

40. Jeste DV and Yassa R: Neuroleptic-induced Tardive Dyskinesia. In: DSM-IV Sourcebook. Edited by Widiger TA, Francis AJ, Pincus HA, First MB, Ross R, Davis W. Washington DC, American Psychiatric Press, 1994, pp 573-582.

41. Tran-Johnson TK, Harris MJ and Jeste DV: Pharmacological treatment of schizophrenia and delusional disorder of late life. In: Principles and Practices of Geriatric Psychiatry. JRM Copeland, MT Abou-Saleh, DG Blazer (eds). New York, John Wiley & Sons, 1994, pp 685-692.

42. Jeste DV, Manley MS, Manley LD and Lohr JB: Behavioral neurochemistry, In: The Behavioral Sciences in Psychiatry, Third edition. JF Wiener and NA Breslin (eds). Malvern, PA: Harwal Publishing, 1995 pp. 3-23.

43. Breslin NA and Jeste DV: Genetics of Behavioral Disorders. In: The Behavioral Sciences in Psychiatry, Third edition. JF Wiener and NA Breslin (eds). Malvern, PA: Harwal Publishing, 1995 pp. 73-86.

44. Jeste DV, Paulsen J and Harris MJ: Late-onset schizophrenia and other related psychoses. In: Psychopharmacology: The Fourth Generation of Progress. FL Bloom, DJ Kupfer (eds). New York, NY: Raven Press 1995 pp. 1437-1446.

45. Harris MJ and Jeste DV: Psychiatric disorders of late life: Schizophrenia and delusional disorder. In: Comprehensive Textbook of Psychiatry. Sixth Edition. HI Kaplan and BJ Sadock (eds). Baltimore: Williams & Wilkins 1995 pp. 2569-2571.

46. Jeste DV, Naimark D, Halpain MC and Lindamer L: Strengths and limitations of research in late-life psychoses. For: Emerging Issues in Mental Health and Aging, (ed) Gatz M, American Psychological Association, Washington DC. 1995 pp. 72-96.

47. Jeste DV, Gilbert PL, Kodsi A, Heaton SC, Lacro JP and Sewell DD: Late-life schizophrenia. In: Schizophrenia. S. Hirsch and D. Weinberger (eds). Blackwell Scientific, London, pp. 73-86, 1995.

48. Jeste DV: Place for Research in Biological Psychiatry in Developing Countries. In: Methods in Biological Psychiatry. S. Khanna, S.M. Channabasavanna and M.S. Keshavan (eds), Tata-McGraw Hill, New Delhi, India, pp v-viii, 1995.

49. Halpain MC, Heaton SC, Warren KA, Lacro JP and Jeste DV: Health Care Utilization Patterns in Late Life Schizophrenia: Case Histories. In: Aging, Health, and Healing, edited by Bergener M., Brocklehurst J. and Finkel SI. New York: Springer Publishing Company, Inc. 1995, p. 585 592.

50. Jeste DV, Harris MJ and Paulsen JS: Psychoses. In: Comprehensive Review of Geriatric Psychiatry, Second edition. J Sadavoy, L Lazarus, L Jarvik and G Grossberg (eds). Washington, DC: American Psychiatric Press, 593-614, 1996.

51. Jeste DV, Galasko D, Corey-Bloom J, Walens S and Granholm E: Neuropsychiatric aspects of the schizophrenias. In: Neuropsychiatry: A Comprehensive Textbook. Fogel BS, Schiffer RB, Rao SM. Baltimore: Williams & Wilkins. pp. 325-344,1996.

52. Jeste DV and Naimark D: Medication-induced movement disorders. In: Psychiatry. A Tasman, J Lieberman, J Kay (eds.) Philadelphia: W.B. Saunders Company, Vol 2., Chp. 69, pp. 1334-1354, 1996.

53. Magulac M and Jeste DV: Tardive dyskinesia in children and adolescents. In: Neuroleptic-Induced Movement Disorders. R Yassa, NVP Nair and DV Jeste (eds). London: Cambridge University Press. Chp 23, pp.311-337, 1996.

54. Lacro JP and Jeste DV: Role of ethnicity in the development of tardive dyskinesia. In: Neuroleptic-Induced Movement Disorders. NPV Nair, R Yassa and DV Jeste (eds). Chp 22, pp.298-310, 1996.

55. Jeste DV and Lebowitz BD: Coming of age. The Leifer Report, Special Edition, pp. 39-40, 1997.

56. Jeste DV, Eastham JH, Gierz M, Field MG, Morgenstern M and Lacro JP: F.J. Ayd, Jr. (ed). Use of risperidone in the elderly. In: The Art of Rational Risperidone Therapy, AYD Medical Communications, Baltimore, 1997, pp. 147-167.

57. Symonds LL and Jeste DV: Neuroimaging in late-life psychosis. In: Brain Imaging in Clinical Psychiatry. Krishnan KRR and Doraiswamy PM (eds) New York: Marcel Dekker, Inc, 1997, pp 425-448.

58. Eastham JH, Lacro JP, Lohr JB and Jeste DV: Treatment of psychosis in late life. In: Geriatric Psychopharmacology. JC Nelson (ed) New York: Marcel Dekker, Inc., Chp 17, pp 301-326, 1998.

59. Jeste DV, Eastham JH, Lohr JB and Salzman C: Diagnosis of disordered behavior and psychosis. In: Clinical Geriatric Psychopharmacology, 3rd edition. C Salzman (ed), Baltimore: Williams & Wilkins, Ch. 5, 97-105, 1998.

60. Jeste DV, Eastham JH, Lohr JB and Salzman C: Treatment of disordered behavior and psychosis. In: Clinical Geriatric Psychopharmacology, 3rd edition. C Salzman (ed) Baltimore: Williams & Wilkins, Ch. 6, 106-149, 1998.

61. Jeste DV and McClure FS: Psychoses: Diagnosis and treatment in elderly. In: Updates in Geriatric Psychiatry, L. Schneider (ed), Publisher: Jossey-Bass, Ch. 4, 53-70, 1998.

62. Salmon DP, Butters N, Thal L and Jeste DV: Alzheimer disease: Data analysis for DSM-IV task force. In: DSM-IV Sourcebook, Vol IV. Widiger TA, Frances HA, Pincus H, Ross R, First MB, Davis W, and Kline M (eds) Washington, DC: American Psychiatric Press, 91-107, 1998.

63. Morris SK and Jeste DV: Schizophrenia and other psychotic disorders. In: Principles of Geriatric Psychiatry, Hazzard WR, Blass JP, Ettinger Jr. WH, Halter JB, Ouslander JG (eds.), McGraw-Hill, Inc., New York : 1341-1349, 1998.

64. Jeste DV and Sciolla A: Neuroleptic-induced side effects and their pharmacologic treatment. In: Textbook of Psychopharmacology, J. Ananth (ed.). Jaypee Brothers Medical Publishers, Ltd., New Delhi, India: 288-303 (Ch. 23), 1999.

65. Lindamer L, Lacro JP and Jeste DV: Relationship of ethnicity to the effects of antipsychotic medication. In: Cross Cultural Psychiatry, Herrera JM, Lawson WB, Sramek JJ (eds) John Wiley & Sons, Ltd., West Sussex, UK, 193-203, 1999.

66. Lindamer L and Jeste DV: Gender and response to antipsychotic medication. In: Cross Cultural Psychiatry, Herrera JM, Lawson WB, Sramek JJ (eds) John Wiley & Sons, Ltd. West Sussex, 343 353, 1999.

67. Lindamer LA and Jeste DV: Psychotic disorders. In: Geriatric Review Syllabus, 4th ed, Cobbs EL, Duthie EH Jr and Murphy JB (eds): American Geriatrics Society, Kendall/Hunt Publishing Company, Dubuque, IA., 179-183, 1999.

68. Symonds LL and Jeste DV: Late-onset schizophrenia. In: Late-Onset Mental Disorders A. Marenos (ed.), American Psychiatric, Press Washington D.C. 83-97, 1999.

69. Martin J, Jeste DV, Patterson T and Ancoli-Israel S: Light exposure and quality of life in older schizophrenia and schizoaffective disorder patients. In: Biologic Effects of Light, 1998: Holick MF and Jung EG (eds), Kluwer Academic Publishers, Boston MA, 471-473, 1999.

70. Jeste DV, Naimark D, Halpain MC and Cuffel B: Neuropsychiatric and mental health services aspects of tardive dyskinesia. In: Neuropsychiatry and Mental Health Services. F Ovsiew (ed), American Psychiatric Press, Washington, D.C. pp. 335-361, 1999.

71. Eyler Zorrilla LT and Jeste DV: Late-onset schizophrenia: New insights into disease etiology. In: Childhood Onset of “Adult” Psychopathology: Clinical and Research Advances, Rapoport JL (ed), American Psychopathological Association, Washington, D.C. pp.149-165, 1999.

72. McClure FS and Jeste DV: Treatment of late onset schizophrenia and related disorders. In: Late Onset Schizophrenia. Howard R, Rabins PV, Castle DJ (eds), Wrightson Biomedical Publishing Ltd, Petersfield, UK, Philadelphia, USA, pp. 217-232, 1999.

73. Harris MJ and Jeste DV: Schizophrenia and delusional disorders. In: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 7th edition, Volume 2. Sadock BJ and Sadock VA (eds), Williams & Wilkins, Baltimore, pp. 3073-3077, 2000.

74. Lindamer LA, Harris MJ, Gladsjo JA, Heaton R, Paulsen JS., Heaton SC and Jeste DV: Gender and schizophrenia. In: Hormones, Gender and the Aging Brain, MF Morrison (ed.) Baltimore: Cambridge University Press, pp. 223 240, 2000.

75. Samuel W and Jeste DV: Treatment of cognitive and non-cognitive disturbances in dementia (Commentary). In: Dementia, M Maj, N Sartorius (eds), New York: Wiley, Chichester, pp. 262-264, 2000.

76. Gladsjo JA, Eastham JH, Jeste DV: Cognitive impairment in older schizophrenia patients. In: Schizophrenia with Comorbid Conditions. MY Hwang and PC Bermanzohn (eds). American Psychiatric Press, Inc., Washington DC, pp. 125-148, 2001.

77. Sable JA, Lacro J, Kennedy JS, Jeste DV: Geriatric Schizophrenia. In Current Issues in the Psychopharmacology of Schizophrenia. Breier A, Tran PV, Herrea JM, Tollefson GD, Bymaster FP (eds). Lippincott Williams & Wilkins, Philadelphia, PA. pp. 417-429, 2001.

78. Sable JA, Jeste DV: Use of antipsychotic drugs in dementia. In Alzheimer’s Disease and Related Disorders Annual 2001. In: Gauthier S, Cummings J. Martin (eds.) Dunitz Ltd. 143-163, 2001.

79. Jeste DV and Martinez RA: Treatment of elderly patients with dementia: Efficacy and tolerability of risperidone. In: Research and Practice in Alzheimer’s Disease Volume 6, Vellas B, Fitten LJ, Winblad B, Feldman H, Grundman M, Giacobini E, Kurz A (eds.) New York, NY: Springer Publishing Company, 198-201, 2002.

80. Lindamer LA, Lacro JP and Jeste DV: Sex-related differences in antipsychotic-induced movement abnormality. In: Psychiatric Illness in Woman: Emerging Treatments and Research, Lewis-Hall F, Williams TS, Panetta JA, Herrera JM (eds.) Washington, DC: American Psychiatric Publishing, Inc., 249-258, 2002.

81. Eyler Zorilla LT, Jeste DV: Schizophrenia. In: Encyclopedia of the Human Brain. Ramchandran VS (ed). San Diego, CA: Academic Press, 251-262, 2002.

82. Lindamer LA, Dunn LB and Jeste DV: Gender and age of onset in schizophrenia. In: Pearson K, Sonawalla S, Rosenbaum J (eds). Women’s Health and Psychiatry 149-158, 2002.

83. Lehman AF, Alexopoulos GS, Goldman H, Jeste D and Ustun: Mental disorders and disability: Time to reevaluate the relationship? In: Kupfer DJ, First MB Regier DA (eds). A Research Agenda for DSM-V 201-218, 2002.

84. Rajkumar S, Ganguli M, and Jeste DV. Dementia in the Indian subcontinent. In: Copeland JRM, Abou-Saleh MT, and Blazer DG (eds.) Principles and Practice of Geriatric Psychiatry, 2nd Edition. London: John Wiley & Sons, 2002.

85. Eyler Zorrilla LT and Jeste DV. Late-life psychotic disorders: Nosology and classification. In Copeland JRM, Abou-Saleh MT, and Blazer DG (eds.), Principles and Practice of Geriatric Psychiatry, 2nd Edition. London: John Wiley & Sons, pp. 493-496, 2002.

86. Howard R, Jeste DV: Late-onset schizophrenia. In: Hirsch S and Weinberger D (eds.). Schizophrenia. Oxford: Blackwell Science Ltd., pp. 68-79, 2003.

87. Jeste DV and Dolder CR: Medication-induced movement disorders. In Tasman A, Lieberman J, and Kay J (eds.) Psychiatry-Second Edition, London, UK: John Wiley and Sons, Ltd. 1657-1676, 2003.

88. Twamley EW, Dolder CR, Corey-Bloom J and Jeste DV: Neuropsychiatric aspects of schizophrenia. In: Schiffer RB, Rao SM, and Fogel BS (eds.) Neuropsychiatry-Second Edition, Philadelphia: Lippincott Williams & Wilkins pp. 776-798, 2003.

89. Palmer BW, Nayak G and Jeste DV: A Comparison of Early- and Late-Onset Schizophrenia. In Cohen C (ed). Schizophrenia into Later Life, Arlington, VA: American Psychiatric Publishing, Inc. pp. 43-54, 2003.

90. Kasckow JW, Mohamed S, Zisook S and Jeste DV: Use of novel antipsychotics in older patients with schizophrenia. In Cohen C (ed). Schizophrenia into Later Life, Arlington, VA: American Psychiatric Publishing, Inc. pp. 195-204, 2003.

91. Bartels SJ, Dums AR, Oxman TE, Schneider LS, Arean PA, Alexopoulos GS and Jeste DV: Evidence-based practices in geriatric mental health care: An overview of systematic reviews and meta-anlyses. In Drake RE (ed.) Evidence-based Practices in Mental Health Care, The Psychiatric Clinics of North America, Philadelphia: W.B. Saunders Company 971-990, 2003.

92. Mohamed S, Kasckow JW, Granholm E and Jeste DV: Community-based treatment of schizophrenia and other severe mental illnesses. In Cohen C (ed). Schizophrenia into Later Life, Arlington, VA: American Psychiatric Publishing, Inc. pp. 205-222, 2003.

93. Jeste DV, Wetherell JL and Dolder CR: Schizophrenia and Paranoid Disorders. In Blazer DG, Steffens DC and Busse EW (eds.) The American Psychiatric Press Textbook of Geriatric Psychiatry, (Third Edition), Washington, DC: American Psychiatric Press. pp. 269-281, 2004.

94. Jeste DV, Dunn LB, Lindamer LA: Psychoses. In Comprehensive Textbook of Geriatric Psychiatry (Third Edition). Sadavoy J, Javik LF, Grossberg GT, Meyers BS (eds.). New York, NY: American Association of Geriatric Psychiatry. pp. 655-685, 2004.

95. Dolder CR, Lacro JP and Jeste DV: Antipsychotics. In Roose and Sackeim (eds.) Late Life Depression Textbook. New York, NY: Oxford University Press pp. 232-240, 2004.

96. Folsom DP, Sable J, and Jeste DV: Psychopharmacology. In: Post (ed.) Encyclopedia of Bioethics. Vol. 4. 3rd ed. New York, NY: Macmillan Reference USA, pp. 2186-2193, 2004.

97. Jeste DV: From schizophrenia and tardive dyskinesia to geriatric psychiatry: An autobiographical account. In Ban TA, Healy D and Shorter E (eds.) Reflections on Twentieth-Century Psychopharmacology: The History of Psychoneuropharmacology and the CINP, Volume IV. Budapest, Hungary: Animula Publishing House, pp. 392-397, 2004.

98. Jeste DV, Sable JA, and Salzman C: Diagnosis of late-life disordered behavior, agitation, and psychosis. In Salzman C (ed.) Clinical Geriatric Psychopharmacology, 4th Edition. Baltimore, MD: Lippincott Williams & Wilkins, pp. 117-27, 2005.

99. Jeste DV, Sable JA, and Salzman C: Treatment of late-life disordered behavior, agitation, and psychosis. In Salzman C (ed.) Clinical Geriatric Psychopharmacology, 4th Edition. Baltimore, MD: Lippincott Williams & Wilkins, pp. 129-195, 2005.

100. Jeste DV and Dolder CR: Schizophrenia and delusional disorders. In Sadock BJ and Sadock VA (eds.) Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 8th Edition, Philadelphia: Lippincott Williams &Wilkins, pp. 3700-3706, 2005.

101. Seeman M and Jeste DV: Historical perspective. In Hassett A, Ames D, and Chiu E (eds.): Psychosis in the Elderly, New York: Taylor & Francis Group , pp. 1-9, 2005.

102. Jeste DV, Dunn LB, Lindamer LA: Psychoses. In Sadavoy J, Jarvik LF, Grossberg GT, and Meyers BS (eds.): Comprehensive Textbook of Geriatric Psychiatry, 3rd Edition, Study Guide. New York: W.W. Norton and Company, pp. 46-48 and 205-211, 2005.

103. Naimark D, Collumb E, Haroun AM and Jeste DV: Neuroleptic-induced movement disorders. In Agronin ME and Maletta GJ (eds.): Principles and Practice of Geriatric Psychiatry. Philadelphia, PA: Lippincott Williams & Willkins, pp. 637-655, 2006.

104. Friedman J and Jeste DV: Preface. In Jeste DV and Friedman J (eds.): Psychiatry for Neurologists. Totowa, New Jersey: Humana Press pp. ix-x, 2006.

105. Miller AL, McEvoy JP, Jeste DV, and Marder SR: In Lieberman JA, Stroup TS, and Perkins DO (eds.): The American Psychiatric Publishing Textbook of Schizophrenia. Washington, DC: American Psychiatric Publishing, Inc. pp. 365-381, 2006.

106. Mackin RS, Depp C, Arean P, and Jeste DV: Overview of psychiatric assessment with dementia patients. In Yeo G, Gallagher-Thompson D (eds.): Ethnicity and the Dementias. New York: Routledge Taylor & Francis Group. pp. 13-32, 2006.

107. Nayak GV, Folsom DP, Twamley EW, and Jeste DV: Treatment of late-life schizophrenia. In Sharma T and Harvey P (eds.): The Early Course of Schizophrenia. New York: Oxford University Press. pp. 225-236, 2006.

108. Jeste DV and Dolder CR: Schizophrenia and paranoid disorders. In Blazer DG, Steffens DC and Busse EW (eds.): Essentials of Geriatric Psychiatry. Washington, DC: American Psychiatric Publishing, Inc. pp. 177-192, 2007.

109. Jeste DV, Meeks TW, Kim DS and Zubenko GS: Diagnostic categories and criteria for neuropsychiatric syndromes in dementia: Research Agenda for DSM-V. In Sunderlan T, Jeste DV, Baiyewu O, Sirovatka PJ and Regier DA (eds.): Diagnostic Issues in Dementia: Advancing the Researc Agenda for DSM-V. Arlington, VA: American Psychiatry Assocation. pp. 77-98, 2007.

110. Dolder CR, Depp CA and Jeste DV: Biological treatments of bipolar disorder in later life. In Sajatovic M and Blow FC (eds.): Bipolar Disorder in Later Life. Baltimore, MD: The Johns Hopkins University Press. pp. 71-93, 2007.

111. Mueser KT and Jeste DV: Preface. In Mueser KT and Jeste DV (eds): Clinical Handbook of Schizophrenia. New York: Guilford Press pp. xiii-xvi, 2008.

112. Meeks TW and Jeste DV: Older Individuals. In Mueser KT and Jeste DV (eds): Clinical Handbook of Schizophrenia. New York: Guilford Press pp. 390-397, 2008.

113. Jeste DV, Lanouette N and Vahia I: Schizophrenia and paranoid disorders. In Blazer DG and Steffens DC (eds.): The American Psychiatric Publishing Textbook of Geriatric Psychiatry, Fourth Edition. Washington, DC: American Psychiatric Publishing, Inc. pp. 317-331, 2009.

114. Savla GN, DelaPena-Murphy J, Sewell DD, Kim DS and Jeste DV: Schizophrenia and other psychotic disorders. In Reichman and Katz (eds.): Psychiatry in Long-Term Care, 2nd Ed. Oxford University Press 149-168, 2009.

115. Jeste DV: Introduction to the Geriatric Psychiatry Section. In Sadock, Sadock, and Ruiz (eds.): Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 9th Ed. Philadelphia, PA: Lippincott Williams & Wilkins 3932-3940, 2009.

116. Depp CA, Vahia I and Jeste DV: Successful Aging. In Sadock, Sadock, and Ruiz (eds.): Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 9th Ed. Philadelphia, PA: Lippincott Williams & Wilkins 4245-4258, 2009.

117. Meeks TW and Jeste DV: Complementary and Alternative Medicine (CAM) in Geriatric Psychiatry. In Sadock, Sadock, and Ruiz (eds.): Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 9th Ed. Philadelphia, PA: Lippincott Williams & Wilkins 3959-3971, 2009.

118. Depp CA and Jeste DV: Phenotype(s) of Successful Aging: Historical Overview. In Depp CA and Jeste DV (eds): Successful Cognitive and Emotional Aging. Arlington, VA: American Psychiatric Press, Inc., pp. 399-402, 2009.

119. Jeste DV and Depp CA: Epilogue. In Depp CA and Jeste DV (eds): Successful Cognitive and Emotional Aging. Arlington, VA: American Psychiatric Press, Inc., 2009.

120. Depp C, Vahia IV, and Jeste DV: Successful Aging: Focus on cognitive and emotional health. In Nolen-Hoeksema S, Cannon T, and Widiger T (eds): Annual Review of Clinical Psychology, Volume 6. Palo Alto, California, Annual Reviews, pp. 527-550, 2010.

121. Meeks TW and Jeste DV: Medication-induced movement disorders. In Psychiatry, Third Edition. Chichester, England: John Wiley & Sons Ltd. (in press, 2010).

122. Sable JA and Jeste DV: Pharmacologic management of psychosis in the elderly. In Camus V and Clement JP (eds): Perspectives en Psychiatrie de la persona agee: Psychoses vieillies, psychoses tardives. Paris: Serdi Ed. (Perspective in Old Age Psychiatry (French Translation)) (in press, 2010).

123. Depp CA and Jeste DV: Schizophrenia, paranoia and delusional disorders. In Markides KS (ed.): Encyclopedia of Health and Aging. Thousand Oaks, CA: SAGE Publications (in press, 2010). 

124. Howard R and Jeste DV: Late-Onset Schizophrenia. In Weinberger and Harrison (eds.): Schizophrenia, 2nd Edition. Oxford: Blackwell Science Ltd. (in press, 2010).

125. Naimark D, Collumb E, Haroun AM, and Jeste DV: Neuroleptic-induced movement disorders. In Agronin ME and Maletta GJ (eds.): Principles and Practice of Geriatric Psychiatry. Philadelphia, PA: Lippincott Williams & Willkins (in press, 2010).

126. Miller AL, McEvoy JP, Jeste DV and Marder SR: Treatment of chronic schizophrenia. In Lieberman J, Perkins D and Stroup S (eds.): Essentials of Schizophrnenia. Arlingon, VA: American Psychiatric Publishing (submitted 2010).

127. Iglewicz A, Vahia IV, and Jeste DV: Cognitive disorders. In Roberts LW, Balon R, Layde JB (eds.). International Handbook of Psychiatry: A Concise Guide for Medical Students, Residents, and Medical Practitioners. World Scientific Publishing Co. Pte. Ltd: Singapore (submitted, 2010).

Other Publications

1. Patterson TL, Lacro JP and Jeste DV: Abuse and misuse of medications in the elderly. Psychiatric Times 16 (4): 54-57, 1999.

2. Jeste DV: Aging and mental illness. In: Time, June 3, 2001, p. 3.

3. Jeste DV: Depression: A treatable malady. In: Esquire, November 2002, pp. 88-91.

4. Jeste DV and Twamley EW: Understanding and managing psychosis in late life. Psychiatric Times 20 (3): 19-22, 2003.

5. Wetherell JL and Jeste DV: Schizophrenia in the elderly. ElderCare 3(2): 8-11, 2003.

6. Jeste DV: American Journal of Geriatric Psychiatry – the journal with the highest increase in citations in psychiatry / psychology during Oct.-Dec. 2002 http://www.in-cites.com April 1, 2003.

7. Jeste DV: Geriatric psychiatry emergencies. Psychiatric Issues in Emergency Care Settings. Winter 2003, pp.15-16.

8. Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R and Docherty JP: Treatment of dementia and its behavioral disturbances. Postgraduate Medicine, January 2005, pp. 3-110.

9. Streim JE, Beier MT, Jeste DV, Tariot PN: Atypical Antipsychotics and the Geriatric Patient: Balancing Safety and Efficacy. A Supplement to Geriatrics, July 2007, pp. 3-18.

10. Jeste DV, Blazer D, Casey DE, Meeks T, Salzman C, Schneider L, Tariot P and Yaffe K: ACNP White Paper: latest update on antipsychotic use in elderly dementia patients. Brown University Geriatric Psychopharmacology Update. 11(10):1, 4-6, 2007.

11. Depp CA, Vahia I and Jeste DV: The intersection of mental health and successful aging. Psychiatric Times 24(13):2007.

12. Jeste DV: Side effects of antipsychotics in the elderly. (Q & A with the Expert). The Carlat Psychiatry Report. 6(4):4-5, April 2008.

13. Levitt PR, March JS, Bell CC, Canino GJ, Childs E, Cohen JD, Desimone R, Geschwind DH, Gur RE, Hollenbeck PJ, Jeste DV, Kelly JA, Knight-Richardson N, Kraemer HC, Lewis DA, Proctor EK, Vogel-Scibilia SE, and Insel TR: Transformative Neurodevelopmental Research in Mental Illness: Report of the National Advisory Mental Health Council’s Workgroup, 27 pages, 2008.

14. Jeste DV: Schizophrenia and aging in Glick ID, Balon R, Zisook S, et al. (eds.), ASCP Model Psychopharmacology Curriculum, 5th Edition, American Society of Clinical Psychopharmacology, Glen Oaks, NY, 2008.

15. Jeste DV: Psychosis and agitation in dementia, in Glick ID, Balon R, Zisook S, et al. (eds.), ASCP Model Psychopharmacology Curriculum, 5th Edition, American Society of Clinical Psychopharmacology, Glen Oaks, NY, 2008.

16. Jeste DV, Barondes S, Blakely RD, Bruce ML, Canino GJ, Cohen JD, Davidson RJ, Escobar JI, Gur RE, Hollenbeck PJ, Knight-Richardson N, Leckman JF, Lipscombe D, MacLeish PR, Neale MC, Proctor EK, Ressler KJ, Rieder RO, Sisk CL, and Insel TR: Investing in the Future: Report of the National Advisory Mental Health Council Workgroup on Research Training, 48 pages, 2008.

17. Norcross WA and Jeste DV: Successful aging: Alive and well in San Diego. San Diego Physician, 97:5:24-27, 2010.